Processing 00000000.tx.1: SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein Koichiro Nakamura1,+, Seon-Yong Jeong2, Toshiki Uchihara3, Midori Anno4, Kazuo Nagashima2,5, Toshiko Nagashima6, Shu-ichi Ikeda7, Shoji Tsuji8 and Ichiro Kanazawa1,2 1Department of Neurology, Division of Neuroscience, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan, 2CREST, Japan Science and Technology Corporation, Tokyo, Japan, 3Department of Neuropathology, Tokyo Metropolitan Institute for Neuroscience, 26 Musashidai, Fuchu, Tokyo 183-8526, Japan, 4Department of Neurology, Tokyo Metropolitan Matsuzawa Hospital, 2-1-1 Kamikitazawa, Setagaya-ku, Tokyo 156-0057, Japan, 5Laboratory of Molecular and Cellular Pathology, Hokkaido University School of Medicine, Kita 15, Nishi 7, Kita-ku, Sapporo 060-8638, Japan, 6Department of Neurology, Teine Keijinkai Hospital, Sapporo, Japan, 7Third Department of Internal Medicine, School of Medicine, Shinshu University, 3-3-1 Asahi, Matsumoto 390-8621, Japan and 8Department of Neurology, Brain Research Institute, Niigata University, 1 Asahimachi, Niigata 951-8585, Japan Received March 29, 2001; 

Phrase: "SCA17,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0144555:SCA17 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1705304:SCA17 [Gene or Genome]
  1000   C1846707:SCA17 [Disease or Syndrome]

Phrase: "a novel autosomal dominant cerebellar ataxia"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   840   C0007758:Cerebellar Ataxia [Sign or Symptom]
   840   C0443147:Autosomal dominant [Intellectual Product]
   804   C0004134:Ataxia [Sign or Symptom]
   804   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   804   C0596142:autosomal [Cell Component]
   804   C1527180:Dominant [Functional Concept]
   804   C1707522:Cerebellar [Tissue]
   733 E C0234366:Ataxic [Sign or Symptom]

Phrase: "caused by an expanded polyglutamine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205229:expanded [Spatial Concept]
   760   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]

Phrase: "in TATA-binding protein Koichiro Nakamura1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "+,"

Phrase: "Seon-Yong Jeong2,"

Phrase: "Toshiki Uchihara3,"

Phrase: "Midori Anno4,"

Phrase: "Kazuo Nagashima2,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "Toshiko Nagashima6,"

Phrase: "Shu-ichi Ikeda7,"

Phrase: "Shoji Tsuji8"

Phrase: "and"

Phrase: "Ichiro Kanazawa1,"

Phrase: "2 1Department of Neurology,"

Phrase: "Division of Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1293097:Division [Therapeutic or Preventive Procedure]
   790   C2919030:Division [Organization]
   790   C2919031:Division [Activity]

Phrase: "Graduate School of Medicine,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0870614:graduate school [Manufactured Object,Organization]
   770   C0036375:School [Manufactured Object,Organization]
   770   C0588053:Graduate [Population Group]
   770   C1547183:Graduate [Idea or Concept]

Phrase: "University of Tokyo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040371:Tokyo [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "7-3-1 Hongo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0720890:hongo [Organic Chemical,Pharmacologic Substance]

Phrase: "Bunkyo-ku,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1532717:ku [Quantitative Concept]
   861   C1881335:kU [Quantitative Concept]

Phrase: "Tokyo 113-8655,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "2CREST,"

Phrase: "Japan Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "and"

Phrase: "Technology Corporation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corporation [Organization]

Phrase: "Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "3Department of Neuropathology,"

Phrase: "Tokyo Metropolitan Institute for Neuroscience,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "26 Musashidai,"

Phrase: "Fuchu,"

Phrase: "Tokyo 183-8526,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "4Department of Neurology,"

Phrase: "Tokyo Metropolitan Matsuzawa Hospital,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   875   C0020029:Metropolitan Hospital [Health Care Related Organization]
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C1510665:Hospital [Qualitative Concept]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "2-1-1 Kamikitazawa,"

Phrase: "Setagaya-ku,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1532717:ku [Quantitative Concept]
   861   C1881335:kU [Quantitative Concept]

Phrase: "Tokyo 156-0057,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "5Laboratory of Molecular"

Phrase: "and"

Phrase: "Cellular Pathology,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0596295:cellular pathology [Cell or Molecular Dysfunction]
   861   C0007634:Cellular [Cell]
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0178539:Cellular [Functional Concept]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1516377:Cellularity [Qualitative Concept]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "Hokkaido University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "Kita 15,"

Phrase: "Nishi 7,"

Phrase: "Kita-ku,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1532717:ku [Quantitative Concept]
   861   C1881335:kU [Quantitative Concept]

Phrase: "Sapporo 060-8638,"

Phrase: "Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "6Department of Neurology,"

Phrase: "Teine Keijinkai Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Sapporo,"

Phrase: "Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "7Third Department of Internal Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0036375:School [Manufactured Object,Organization]

Phrase: "Shinshu University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "3-3-1 Asahi,"

Phrase: "Matsumoto 390-8621,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "and"

Phrase: "8Department of Neurology,"

Phrase: "Brain Research Institute,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0035172:Research Institute [Organization]
   827   C0021622:institute [Organization]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C1272753:Institute [Idea or Concept]

Phrase: "Niigata University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "1 Asahimachi,"

Phrase: "Niigata 951-8585,"

Phrase: "Japan Received March 29,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0022341:Japan [Geographic Area]
   812   C1514756:Received [Qualitative Concept]

Phrase: "2001"

Phrase: ";"
Processing 00000000.tx.2: Revised and Accepted May 4, 2001.  

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "May 4,"

Phrase: "2001."
Processing 00000000.tx.3: ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Genetic etiologies of at least 20% of autosomal dominant cerebellar ataxias (ADCAs) have yet to be clarified. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Genetic etiologies of"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0015127:etiologies [Functional Concept]
   756 E C1314792:Etiology [Functional Concept]
   756 E C1524003:Etiology [Conceptual Entity]

Phrase: "at least 20%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439092:less [Intellectual Product]
   827   C0547044:Less [Qualitative Concept]

Phrase: "of autosomal dominant cerebellar ataxias (ADCAs)"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0007758:Cerebellar Ataxias [Sign or Symptom]
   861   C0443147:Autosomal dominant [Intellectual Product]
   812   C0004134:Ataxias [Sign or Symptom]
   812   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   812   C0596142:autosomal [Cell Component]
   812   C1527180:Dominant [Functional Concept]
   812   C1707522:Cerebellar [Tissue]
   729 E C0234366:Ataxic [Sign or Symptom]

Phrase: "have"

Phrase: "yet to"

Phrase: "be"

Phrase: "clarified."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarified [Activity]
Processing 00000000.tx.4: We identified a novel spinocerebellar ataxia (SCA) form in four Japanese pedigrees which is caused by an abnormal CAG expansion in the TATA-binding protein (TBP) gene, a general transcription initiation factor. 

Phrase: "We"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a novel spinocerebellar ataxia (SCA) form in four Japanese pedigrees"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1522492:Form [Functional Concept]

Phrase: "which"

Phrase: "is"

Phrase: "caused by an abnormal CAG expansion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205161:Abnormal [Qualitative Concept]
   753   C2347472:% Abnormal [Quantitative Concept]
   753   C2699333:ABNORMAL [Intellectual Product]
   719   C0015127:cause [Functional Concept]
   719   C1524003:Cause [Conceptual Entity]

Phrase: "in the TATA-binding protein (TBP) gene,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a general transcription initiation factor."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C1135650:General Transcription Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1158830:Transcription Initiation [Genetic Function]
           Initiation
   812   C0040649:Transcription [Genetic Function]
   812   C0589507:Initiation [Mental Process]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.5: Consequently, it has been added to the group of polyglutamine diseases. 

Phrase: "Consequently,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "added to the group of polyglutamine diseases."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   748   C0012634:Diseases [Disease or Syndrome]
   748   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1524062:Added [Functional Concept]
   748   C1552516:Group [Health Care Related Organization]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]
   714 E C1883712:Add [Functional Concept]
Processing 00000000.tx.6: This abnormal expansion of glutamine tracts in TBP bears 4755 repeats, whereas the normal repeat number ranges from 29 to 42. 

Phrase: "This abnormal expansion of glutamine tracts"

Phrase: "in TBP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "bears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004897:Bear [Mammal]

Phrase: "4755 repeats,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205341:repeats [Functional Concept]
   861   C1705914:Repeats [Conceptual Entity]
   827 E C1547730:Repeat [Temporal Concept]

Phrase: "whereas"

Phrase: "the normal repeat number"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0332592:Normal number [Qualitative Concept]
   827   C0237753:*Number [Quantitative Concept]
   827   C0449788:Number [Quantitative Concept]

Phrase: "ranges from 29"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1514721:*Ranges [Quantitative Concept]
   790   C2348147:Range [Quantitative Concept]
   790   C3542016:Range [Intellectual Product]

Phrase: "to 42."
Processing 00000000.tx.7: Immunocytochemical examination of a postmortem brain which carried 48 CAG repeats detected neuronal intranuclear inclusion bodies that stained with anti-ubiquitin antibody, anti-TBP antibody and with the 1C2antibody that recognizes specifically expanded pathological polyglutamine tracts. 

Phrase: "Immunocytochemical examination of a postmortem brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0004398:Post-Mortem Examination [Diagnostic Procedure]
   783   C0555351:Brain examination [Diagnostic Procedure]

Phrase: "which"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "48 CAG"

Phrase: "repeats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205341:Repeat [Functional Concept]
  1000   C1547730:Repeat [Temporal Concept]
  1000   C1705914:Repeat [Conceptual Entity]

Phrase: "detected neuronal intranuclear inclusion bodies"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   884   C1366904:Intranuclear Inclusion Bodies [Cell Component]
   840   C0007637:Inclusion Bodies [Cell Component]
   836   C0230595:Intranuclear body [Cell Component]
   823   C0682679:neuron body [Cell Component]
   804   C0242821:bodies [Human]
   804   C1995017:Bodies [Cell Component]
   771 E C0460148:Body [Anatomical Structure]
   771 E C1268086:Body [Anatomical Structure]

Phrase: "that"

Phrase: "stained with anti-ubiquitin antibody,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "anti-TBP antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and with the 1C2antibody"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "that"

Phrase: "recognizes"

Phrase: "specifically"

Phrase: "expanded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:expanded [Spatial Concept]

Phrase: "pathological polyglutamine tracts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1185740:tracts [Body Part, Organ, or Organ Component]
Processing 00000000.tx.8: We therefore propose that this new disease be called SCA17 (TBP disease).  

Phrase: "We therefore"

Phrase: "propose"

Phrase: "that"

Phrase: "this new disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "be"

Phrase: "called SCA17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0144555:SCA17 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1705304:SCA17 [Gene or Genome]
   861   C1846707:SCA17 [Disease or Syndrome]

Phrase: "(TBP disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0012634:Disease [Disease or Syndrome]
   756   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.9: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Autosomal dominant cerebellar ataxias (ADCAs) make up a complex group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord (1,2). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Autosomal dominant cerebellar ataxias"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0007758:Cerebellar Ataxias [Sign or Symptom]
   861   C0443147:Autosomal dominant [Intellectual Product]
   812   C0004134:Ataxias [Sign or Symptom]
   812   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   812   C0596142:autosomal [Cell Component]
   812   C1527180:Dominant [Functional Concept]
   812   C1707522:Cerebellar [Tissue]
   729 E C0234366:Ataxic [Sign or Symptom]

Phrase: "(ADCAs"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0007758:Cerebellar Ataxias [Sign or Symptom]
   861   C0443147:Autosomal dominant [Intellectual Product]
   812   C0004134:Ataxias [Sign or Symptom]
   812   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   812   C0596142:autosomal [Cell Component]
   812   C1527180:Dominant [Functional Concept]
   812   C1707522:Cerebellar [Tissue]
   729 E C0234366:Ataxic [Sign or Symptom]

Phrase: ")"

Phrase: "make up"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881534:Make [Functional Concept]

Phrase: "a complex group of neurodegenerative disorders"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0441835:Group A [Classification]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]

Phrase: "characterized by progressive degeneration of the cerebellum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   748   C0011164:Degeneration [Pathologic Function]
   748   C0205329:Progressive [Functional Concept]
   748   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   748   C1707522:Cerebellum [Tissue]
   748   C1880022:Characterized [Activity]
   748   C1880269:Degeneration [Functional Concept]

Phrase: "brain stem"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
  1000   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0242767:Stem [Plant]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "spinal cord"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
  1000   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   861   C0521329:Spinal [Spatial Concept]
   861   C1550235:Cord [Body Part, Organ, or Organ Component]
   861   C1552938:cord [Quantitative Concept]
   861   C1706500:Cord [Manufactured Object]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.10: Presently they are classified according to molecular criteria, but the genetic etiologies of at least 20% of the ADCAs have yet to be determined (3). 

Phrase: "Presently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750528:presently [Idea or Concept]

Phrase: "they"

Phrase: "are"

Phrase: "classified according to molecular criteria,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008902:Classified [Classification]
   760   C0243161:criteria [Intellectual Product]
   760   C0680240:according [Social Behavior]
   760   C1521991:Molecular [Qualitative Concept]

Phrase: "but"

Phrase: "the genetic etiologies of"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0015127:etiologies [Functional Concept]
   737 E C1314792:Etiology [Functional Concept]
   737 E C1524003:Etiology [Conceptual Entity]

Phrase: "at least 20%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439092:less [Intellectual Product]
   827   C0547044:Less [Qualitative Concept]

Phrase: "of the ADCAs"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0007758:Cerebellar Ataxias [Sign or Symptom]
   861   C0443147:Autosomal dominant [Intellectual Product]
   812   C0004134:Ataxias [Sign or Symptom]
   812   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   812   C0596142:autosomal [Cell Component]
   812   C1527180:Dominant [Functional Concept]
   812   C1707522:Cerebellar [Tissue]
   729 E C0234366:Ataxic [Sign or Symptom]

Phrase: "have"

Phrase: "yet to"

Phrase: "be"

Phrase: "determined"

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.11: Interestingly, six of the eight gene-proven spinocerebellar ataxias (SCAs): dentato-rubral pallidoluysian atrophy (DRPLA), SCA1, SCA2, SCA3/ MachadoJoseph disease (MJD), SCA6 and SCA7 have been shown to be caused by an unstable CAG trinucleotide expansion mutation coding for polyglutamine tracts in the responsible genes (4). 

Phrase: "Interestingly,"

Phrase: "six of the eight gene-proven spinocerebellar ataxias (SCAs)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   776   C1441233:Spinocerebellar ataxia gene [Gene or Genome]
   770   C0087012:Spinocerebellar Ataxias [Disease or Syndrome]
   744   C0004134:Ataxias [Sign or Symptom]
   744   C0017337:Gene [Gene or Genome]
   744   C0205452:Six [Quantitative Concept]
   744   C0205454:Eight [Quantitative Concept]
   744   C0456369:Proven [Qualitative Concept]

Phrase: ":"

Phrase: "dentato-rubral pallidoluysian atrophy (DRPLA),"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0393578:Pallidoluysian atrophy [Disease or Syndrome]
   812   C0333641:Atrophy [Pathologic Function]
   741 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "SCA1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:SCA-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0752120:SCA1 [Disease or Syndrome]

Phrase: "SCA2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0752121:SCA2 [Disease or Syndrome]
  1000   C1334353:SCA-2 [Gene or Genome]
  1000   C1705387:SCA-2 [Gene or Genome]

Phrase: "SCA3/ MachadoJoseph disease (MJD),"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "SCA6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0752124:SCA6 [Disease or Syndrome]

Phrase: "and"

Phrase: "SCA7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0752125:SCA7 [Disease or Syndrome]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "caused by an unstable CAG trinucleotide expansion mutation coding"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0009219:Coding [Occupational Activity]
   742   C0026882:Mutation [Genetic Function]
   742   C0443343:Unstable [Finding]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]
   742   C1883468:UNSTABLE [Phenomenon or Process]
   708   C0015127:cause [Functional Concept]
   708   C1524003:Cause [Conceptual Entity]

Phrase: "for polyglutamine tracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1185740:tracts [Body Part, Organ, or Organ Component]

Phrase: "in the responsible genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.12: These findings strongly suggest that expansion of the polyglutamine tract is a major pathogenic mechanism for dominant ataxias. 

Phrase: "These findings strongly"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that expansion of the polyglutamine tract"

Phrase: "is"

Phrase: "a major pathogenic mechanism for dominant ataxias."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.13: By screening for expanded polyglutamine tracts by western blotting analysis with a monoclonal 1C2 antibody, we recently identified a new dominant ataxia caused by the expansion of polyglutamine tracts in the TATA-binding protein (TBP), a general transcription initiation factor. 

Phrase: "By screening"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0220908:Screening [Health Care Activity]
  1000   C0220909:screening [Functional Concept]
  1000   C1698960:screening [Intellectual Product]
  1000   C1710031:Screening [Diagnostic Procedure]
  1000   C1710477:SCREENING [Research Activity]

Phrase: "for expanded polyglutamine tracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1185740:tracts [Body Part, Organ, or Organ Component]

Phrase: "by western blotting analysis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   988   C0949466:Western blot analysis [Laboratory Procedure]
       E   Western Blot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "with a monoclonal 1C2 antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "we recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a new dominant ataxia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0004134:Ataxia [Sign or Symptom]
   755 E C0234366:Ataxic [Sign or Symptom]

Phrase: "caused by the expansion of polyglutamine tracts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   748   C1185740:tracts [Body Part, Organ, or Organ Component]
   714   C0015127:cause [Functional Concept]
   714   C1524003:Cause [Conceptual Entity]

Phrase: "in the TATA-binding protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "(TBP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: ","

Phrase: "a general transcription initiation factor."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C1135650:General Transcription Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1158830:Transcription Initiation [Genetic Function]
           Initiation
   812   C0040649:Transcription [Genetic Function]
   812   C0589507:Initiation [Mental Process]
   812   C1521761:Factor [Functional Concept]
   812   C1704686:Initiation [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.14: This locus was registered as SCA17 with the approval of the Genome Nomenclature Committee in HUGO (http://www.gene.ucl.ac.uk/nomenclature/). 

Phrase: "This locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708726:Locus [Gene or Genome]

Phrase: "was"

Phrase: "registered as SCA17"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0144555:SCA17 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1514821:Registered [Health Care Activity]
   790   C1578536:Registered [Finding]
   790   C1705304:SCA17 [Gene or Genome]
   790   C1846707:SCA17 [Disease or Syndrome]

Phrase: "with the approval"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205540:Approval [Qualitative Concept]
  1000   C2346845:Approval [Intellectual Product]

Phrase: "of the Genome Nomenclature Committee"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1709239:Nomenclature Committee [Organization]
   827   C2699414:Committee [Group]

Phrase: "in HUGO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705051:HUGO [Organization]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.gene.ucl.ac.uk/nomenclature/"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0600281:Nomenclature [Intellectual Product]
   799   C1524067:Nomenclature [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.15: Despite intensive investigation over several years, the genetic pathways and molecular mechanisms that underlie the neuronal degeneration in this group of diseases remain unknown. 

Phrase: "Despite intensive investigation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C1261322:Investigation [Health Care Activity]
   861   C1552578:investigation [Idea or Concept]
   789 E C1517586:Investigational [Qualitative Concept]
   789 E C3245491:investigational [Intellectual Product]

Phrase: "over several years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "the genetic pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "and"

Phrase: "molecular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "underlie"

Phrase: "the neuronal degeneration in this group of diseases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0011164:Degeneration [Pathologic Function]
   744   C1880269:Degeneration [Functional Concept]
   735   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]

Phrase: "remain"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.16: Recent findings show that in the mouse and fly models transcriptional dysregulation may have importance in cell dysfunction and eventual cell death (510). 

Phrase: "Recent findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that in the mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "fly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012578:Fly, NOS [Eukaryote]
  1000   C1704307:Fly [Eukaryote]

Phrase: "models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "transcriptional dysregulation"

Phrase: "may"

Phrase: "have"

Phrase: "importance in cell dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0031847:dysfunction [Functional Concept]
   812   C0277785:Dysfunction, NOS [Qualitative Concept]
   756 E C0231174:Malfunction [Functional Concept]
   756 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "eventual cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "(510"

Phrase: ")."
Processing 00000000.tx.17: Our findings provide necessary information for clarifying the pathogenesis of polyglutamine diseases.  

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "necessary information for clarifying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1533716:Information [Idea or Concept]

Phrase: "the pathogenesis of polyglutamine diseases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0543483:pathogenesis [Functional Concept]
   760   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.18: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  1C2 antibody immunoscreening and gene identification We first conducted 1C2 antibody immunoscreening to identify the expanded polyglutamine tract in lymphoblastoid cell lines from 22 probands, for whom expansions of the eight known CAG repeats associated with neurodegenerative diseases [Huntingtons disease (HD), spinobulbar muscular atrophy (SBMA), DRPLA, SCA1, SCA2, SCA3, SCA6, SCA7] had already been excluded by PCR analysis. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1C2 antibody immunoscreening"

Phrase: "and"

Phrase: "gene identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020792:Identification [Mental Process]
   861   C0205396:Identification [Qualitative Concept]

Phrase: "We first conducted 1C2 antibody immunoscreening to"

Phrase: "identify"

Phrase: "the expanded polyglutamine tract in lymphoblastoid cell lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1185740:Tract [Body Part, Organ, or Organ Component]

Phrase: "from 22 probands,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0702111:probands [Organism Attribute]
   827 E C1948021:Proband [Family Group]
   789 E C0702110:Propositus [Organism Attribute]

Phrase: "for whom expansions"

Phrase: "of the eight known CAG repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0205341:repeats [Functional Concept]
   812   C1705914:Repeats [Conceptual Entity]
   779 E C1547730:Repeat [Temporal Concept]

Phrase: "associated with neurodegenerative diseases"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   802   C0243083:associated disease [Pathologic Function]
   770   C0012634:Diseases [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "[Huntingtons disease (HD),"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0020179:Huntington Disease [Disease or Syndrome]
  1000   C2919056:Huntington's Disease [Functional Concept]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "spinobulbar muscular atrophy (SBMA),"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0752353:Atrophy, Muscular, Spinobulbar [Disease or Syndrome]
           Spinobulbar Atrophy
   901   C0026846:Muscular Atrophy [Disease or Syndrome]
   827   C0026845:Muscular [Tissue]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0442025:Muscular [Spatial Concept]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C1995013:Muscles [Body Part, Organ, or Organ Component]

Phrase: "DRPLA,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0393578:Pallidoluysian atrophy [Disease or Syndrome]
   812   C0333641:Atrophy [Pathologic Function]
   741 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "SCA1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:SCA-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0752120:SCA1 [Disease or Syndrome]

Phrase: "SCA2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0752121:SCA2 [Disease or Syndrome]
  1000   C1334353:SCA-2 [Gene or Genome]
  1000   C1705387:SCA-2 [Gene or Genome]

Phrase: "SCA3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024408:SCA3 [Disease or Syndrome]

Phrase: "SCA6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0752124:SCA6 [Disease or Syndrome]

Phrase: "SCA7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0752125:SCA7 [Disease or Syndrome]

Phrase: "]"

Phrase: "had"

Phrase: "already"

Phrase: "been"

Phrase: "excluded by PCR analysis."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0200931:PCR analysis [Laboratory Procedure]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C1554077:Excluded [Idea or Concept]
   770   C2828389:Excluded [Activity]
   737 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.19: Mouse monoclonal 1C2 antibody specifically recognizes proteins of largely expanded polyglutamine tracts, particularly those in pathological ranges (greater than 40 glutamines) (11). 

Phrase: "Mouse monoclonal 1C2 antibody specifically"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   888   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   853   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "recognizes"

Phrase: "proteins of largely expanded polyglutamine tracts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "particularly"

Phrase: "those in pathological ranges"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0030664:Pathological [Biomedical Occupation or Discipline]
   770   C1514721:*Ranges [Quantitative Concept]
   770   C1521733:Pathological [Functional Concept]
   737 E C2348147:Range [Quantitative Concept]
   737 E C3542016:Range [Intellectual Product]

Phrase: "(greater than 40 glutamines"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0439093:Greater Than [Quantitative Concept]
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: ")"

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.20: Using the method described by Stevanin et al. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "described by Stevanin et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.21: (12) but with modifications, we identified a new polyglutamine protein of 49 kDa in one proband (Fig. 1). 

Phrase: "(12"

Phrase: ")"

Phrase: "but with modifications,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0233535:but [Mental or Behavioral Dysfunction]
   756   C0392747:Modification [Functional Concept]
   756   C1554963:modification [Qualitative Concept]

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a new polyglutamine protein of 49 kDa"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in one proband"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1948021:Proband [Family Group]
   805 E C0702110:Propositus [Organism Attribute]
   777 E C0702111:probands [Organism Attribute]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.22: Its molecular weight differs from that of any of the known polyglutamine proteins, strongly indicative that this 49 kDa band is a product of a new gene encoding a polyglutamine tract. 

Phrase: "Its molecular weight"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0026385:Molecular Weight [Quantitative Concept]
   861   C0005910:weight [Organism Attribute]
   861   C0043100:Weight [Quantitative Concept]
   861   C1305866:weight [Diagnostic Procedure]
   861   C1521991:Molecular [Qualitative Concept]
   861   C1705104:Weight [Idea or Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "differs from that of any of the known polyglutamine proteins,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205309:Known [Qualitative Concept]
   739   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]

Phrase: "strongly indicative"

Phrase: "that"

Phrase: "this 49 kDa band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]

Phrase: "is"

Phrase: "a product of a new gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0681520:new product [Intellectual Product,Manufactured Object]
   783   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1514468:product [Entity]
   753   C1704444:Product [Quantitative Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a polyglutamine tract."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1185740:Tract [Body Part, Organ, or Organ Component]
Processing 00000000.tx.23: Given the similarity of its apparent molecular weight to that of the TBP, we speculated that this 49 kDa protein might be mutant TBP, which is supported by the fact that the monoclonal 1C2 antibody was originally raised against TBP (11). 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the similarity of its apparent molecular weight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similarity [Qualitative Concept]

Phrase: "to that"

Phrase: "of the TBP,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "we"

Phrase: "speculated"

Phrase: "that"

Phrase: "this 49 kDa protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "be"

Phrase: "mutant TBP,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "which"

Phrase: "is"

Phrase: "supported by the fact"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "that"

Phrase: "the monoclonal 1C2 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "originally"

Phrase: "raised against TBP"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797 E C0033618:Protein Binding [Molecular Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0243122:binding [Functional Concept]
   760   C0442818:Raised [Quantitative Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.24: Using the primer pairs flanking the CAG/CAA repeat of the TBP gene, we found that both the proband and his affected sibling had the same repeat expansions (Fig. 2A). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the primer pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709450:Pair [Qualitative Concept]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "the CAG/CAA repeat of the TBP gene,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0205341:Repeat [Functional Concept]
   739   C1547730:Repeat [Temporal Concept]
   739   C1705914:Repeat [Conceptual Entity]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "both the proband"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1948021:Proband [Family Group]
   944 E C0702110:Propositus [Organism Attribute]
   916 E C0702111:probands [Organism Attribute]

Phrase: "and"

Phrase: "his affected sibling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037047:Sibling [Family Group]
   861   C1611273:Sibling [Intellectual Product]

Phrase: "had"

Phrase: "the same repeat expansions"

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.25: We therefore determined the CAG/CAA repeat numbers of the TBP genes of the two affected siblings and their mother in pedigree A (Fig. 3A). 

Phrase: "We therefore"

Phrase: "determined"

Phrase: "the CAG/CAA repeat numbers of the TBP genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0237753:*Number [Quantitative Concept]
   738   C0449788:Number [Quantitative Concept]

Phrase: "of the two affected siblings"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0037047:Siblings [Family Group]
   793 E C1611273:Sibling [Intellectual Product]

Phrase: "and"

Phrase: "their mother in pedigree A (Fig. 3A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0026591:Mother [Family Group]

Phrase: ")."
Processing 00000000.tx.26: The CAG/CAA repeat number for TBP in the healthy mother was 37/39, whereas the numbers in the affected siblings were heterozygous, 37/55 and 39/55 (Fig. 3D and Table 1). 

Phrase: "The CAG/CAA repeat number for TBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0237753:*Number [Quantitative Concept]
   742   C0449788:Number [Quantitative Concept]

Phrase: "in the healthy mother"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0026591:Mother [Family Group]
   805 E C1826438:MATER [Gene or Genome]
   805 E C2347083:Maternal [Family Group]

Phrase: "was"

Phrase: "37/39,"

Phrase: "whereas"

Phrase: "the numbers in the affected siblings"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "were"

Phrase: "heterozygous, 37/55"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0019425:Heterozygous [Organism Attribute]
   827   C0450382:55 [Intellectual Product]

Phrase: "and"

Phrase: "39/55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: "(Fig. 3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: "and"

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.27: The identity of the 49 kDa band was confirmed by western blot analysis of protein extracts from the probands lymphoblasts using the monoclonal anti-TBP antibody which recognizes an epitope within N-terminal amino acid residues 120 of TBP. 

Phrase: "The identity of the 49 kDa band"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0424215:Identity [Mental Process]
   748   C2003939:Identity [Finding]

Phrase: "was"

Phrase: "confirmed by western blot analysis of protein"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   866   C2121086:protein analysis by Western blot [Laboratory Procedure]
   814   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   778   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   778   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   774   C1514534:Protein Analysis [Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0750484:Confirmed [Idea or Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1705493:Western [Spatial Concept]
   714 E C1456348:Confirm [Qualitative Concept]

Phrase: "extracts from the probands lymphoblasts"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0229613:Lymphoblasts [Cell]
   760   C0702111:probands [Organism Attribute]
   760   C1167770:Lymphoblasts [Laboratory Procedure]
   760   C2828366:Extract [Substance]
   726 E C1948021:Proband [Family Group]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the monoclonal anti-TBP antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   895   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   876   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   709   C0443737:Monoclonal protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   709   C0700271:monoclonal protein [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "which"

Phrase: "recognizes"

Phrase: "an epitope within N-terminal amino acid residues 120"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0003316:Epitope [Immunologic Factor]

Phrase: "of TBP."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
Processing 00000000.tx.28: It clearly shows that his lymphoblasts (Fig. 2B, lane 2; pedigree A, III-1) expressed an equal amount of abnormally large TBP (49 kDa, upper band) as compared with the wild-type TBP (lower band). 

Phrase: "It clearly"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "his lymphoblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0229613:Lymphoblasts [Cell]
  1000   C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "; pedigree A,"

Phrase: "III-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "expressed"

Phrase: "an equal amount of abnormally large TBP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1265611:Amount [Quantitative Concept]

Phrase: "(49 kDa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "upper band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: ")"

Phrase: "as"

Phrase: "compared with the wild-type TBP"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   800   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1883559:Wild Type [Organism Attribute]
   767 E C0033618:Protein Binding [Molecular Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0243122:binding [Functional Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1547052:*Type [Quantitative Concept]
   744   C1707455:Compared [Activity]

Phrase: "(lower band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: ")."
Processing 00000000.tx.29: The intensities of the wild-type TBP bands in the western blots differ in Figure 1, lane 6 and Figure 2B, lane 2. 

Phrase: "The intensities of the wild-type TBP bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0522510:intensities [Qualitative Concept]

Phrase: "in the western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "differ in Figure 1,"

Phrase: "lane 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "Figure 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "lane 2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]
Processing 00000000.tx.30: This is probably due to differences in the reactivities of the 1C2 and anti-TBP antibodies. 

Phrase: "This"

Phrase: "is"

Phrase: "probably due to differences"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0750492:Probably [Idea or Concept]
   770   C3146286:Due [Idea or Concept]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "in the reactivities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0205332:Reactive [Qualitative Concept]

Phrase: "of the 1C2"

Phrase: "and"

Phrase: "anti-TBP antibodies."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   897   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   881 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   823   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.31: View larger version (89K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(89K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.32: Identification of a novel 49 kDa polyglutamine protein in lymphoblasts from the proband in pedigree A. 

Phrase: "Identification of a novel 49 kDa polyglutamine protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0020792:Identification [Mental Process]
   744   C0205396:Identification [Qualitative Concept]

Phrase: "in lymphoblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0229613:Lymphoblasts [Cell]
  1000   C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: "from the proband"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1948021:Proband [Family Group]
   944 E C0702110:Propositus [Organism Attribute]
   916 E C0702111:probands [Organism Attribute]

Phrase: "in pedigree A."
Processing 00000000.tx.33: The immunoblot of solubilized protein extracts from lymphoblasts, made with monoclonal 1C2 antibody, has a TBP (41 kDa) band in all the lanes (closed square). 

Phrase: "The immunoblot of solubilized protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "extracts from lymphoblasts,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0229613:Lymphoblasts [Cell]
   790   C1167770:Lymphoblasts [Laboratory Procedure]
   790   C2828366:Extract [Substance]

Phrase: "made with monoclonal 1C2 antibody,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0746619:monoclonal [Finding]
   726   C1881534:Make [Functional Concept]

Phrase: "has"

Phrase: "a TBP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "(41 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "band in all"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0175723:Band [Medical Device]
   790   C0439645:Band [Spatial Concept]
   790   C1521913:band [Cell Component]

Phrase: "the lanes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708639:Lane [Spatial Concept]

Phrase: "(closed square"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205120:Square [Spatial Concept]
   861   C1552595:Square [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.34: Two proteins, at 200 and 230 kDa, which have the same intensity are visible in the lymphoblastoid extracts from the control MJD patient (lane 1) and all the probands (lanes 29). 

Phrase: "Two proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "at 200"

Phrase: "and"

Phrase: "230 kDa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "which"

Phrase: "have"

Phrase: "the same intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intensity [Qualitative Concept]

Phrase: "are"

Phrase: "visible in the lymphoblastoid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205379:Visible [Qualitative Concept]

Phrase: "extracts from the control MJD patient"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C0920467:control disease [Therapeutic or Preventive Procedure]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0030705:*^patient [Patient or Disabled Group]
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C2828366:Extract [Substance]
   748   C3274648:Control [Qualitative Concept]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "all the probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0702111:probands [Organism Attribute]
   966 E C1948021:Proband [Family Group]
   928 E C0702110:Propositus [Organism Attribute]

Phrase: "(lanes 29"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.35: MJD protein with an expanded polyglutamine tract, molecular weight 60 kDa, (arrowhead) is present in lane 1. 

Phrase: "MJD protein with an expanded polyglutamine tract,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "molecular weight 60 kDa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1532717:kDa [Quantitative Concept]

Phrase: "(arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453107:Arrowhead [Food]
  1000   C1080898:Arrowhead [Plant]

Phrase: ")"

Phrase: "is"

Phrase: "present in lane 1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
Processing 00000000.tx.36: The novel 49 kDa polyglutamine protein (indicated by an asterisk) is present only in the lymphoblastoid extract of the proband in pedigree A (lane 6).  

Phrase: "The novel 49 kDa polyglutamine protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "indicated by an asterisk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1444656:Indicated [Finding]
   770   C2945706:asterisk [Conceptual Entity]

Phrase: ")"

Phrase: "is"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "only in the lymphoblastoid extract of the proband"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205171:Only [Quantitative Concept]
   744   C1720467:Only [Intellectual Product]
   744   C1948021:Proband [Family Group]
   744   C2828366:Extract [Substance]

Phrase: "in pedigree A (lane 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030761:Pedigree [Intellectual Product]
   812   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.37: View larger version (50K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(50K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.38: PCR and immunoblot analysis of TBP of pedigree A. 

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "immunoblot analysis of TBP of pedigree A."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   762   C1514534:Protein Analysis [Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
Processing 00000000.tx.39: (A) Genomic DNAs from a control individual (lane HC), a patient with MJD (lane DC), the mother of the proband (lane 1), the proband (lane 2) and the younger sister of the proband (lane 3) were amplified by the TBP-F/TBP-R primer. 

Phrase: "(A) Genomic DNAs from a control individual"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0000702:A-DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0017428:Genomic [Gene or Genome]
   748   C0887950:genomic [Biomedical Occupation or Discipline]
   745   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   714   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(lane HC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020268:HC [Hormone,Pharmacologic Substance,Steroid]
   861   C1413512:Hc [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "a patient with MJD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:*^patient [Patient or Disabled Group]

Phrase: "(lane DC"

Phrase: ")"

Phrase: ","

Phrase: "the mother of the proband"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0026591:Mother [Family Group]
   704 E C1826438:MATER [Gene or Genome]
   704 E C2347083:Maternal [Family Group]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "the proband"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1948021:Proband [Family Group]
   944 E C0702110:Propositus [Organism Attribute]
   916 E C0702111:probands [Organism Attribute]

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the younger sister of the proband"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0337525:Younger sister [Family Group]
   753   C0337514:Sister [Family Group]

Phrase: "(lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "amplified"

Phrase: "by the TBP-F/TBP-R primer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.40: The fathers genomic DNA was not available because he had died. 

Phrase: "The fathers genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017428:Genomic [Gene or Genome]
   827   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "not available"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548671:Not available [Idea or Concept]
   861   C0470187:Available [Functional Concept]

Phrase: "because"

Phrase: "he"

Phrase: "had"

Phrase: "died."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0011065:Died [Organism Function]
  1000   C1546956:Died [Finding]
   928 E C0231800:Expired [Organ or Tissue Function]
   928 E C1704631:Expire [Idea or Concept]
   907 E C0184532:dying [Organism Function]
   907 E C1553404:terminated [Idea or Concept]
   907 E C2348570:Terminated [Functional Concept]
Processing 00000000.tx.41: The expected molecular size of the PCR product is 245 bp when the TBP gene has 38 CAG/CAA polymorphic repeats. 

Phrase: "The expected molecular size of the PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0596969:molecular size [Quantitative Concept]
   744   C0456389:size [Spatial Concept]

Phrase: "is"

Phrase: "245 bp"

Phrase: "when"

Phrase: "the TBP gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "38 CAG/CAA polymorphic repeats."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0205341:repeats [Functional Concept]
   804   C1705914:Repeats [Conceptual Entity]
   771 E C1547730:Repeat [Temporal Concept]
Processing 00000000.tx.42: Abnormally expanded PCR products of 300 bp are present only in the lanes for the proband and his sister (lanes 2 and 3). 

Phrase: "Abnormally expanded PCR products of 300 bp"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1514468:Products [Entity]
   714 E C1704444:Product [Quantitative Concept]

Phrase: "are"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "only in the lanes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205171:Only [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]
   737   C1708639:Lane [Spatial Concept]

Phrase: "for the proband"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1948021:Proband [Family Group]
   944 E C0702110:Propositus [Organism Attribute]
   916 E C0702111:probands [Organism Attribute]

Phrase: "and"

Phrase: "his sister"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337514:Sister [Family Group]

Phrase: "(lanes 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.43: Numbers on the left side of the gel give the molecular marker size ( x 174/HaeIII). 

Phrase: "Numbers on the left side of the gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "the molecular marker size"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0596969:molecular size [Quantitative Concept]
   827   C0456389:size [Spatial Concept]
   734   C0005516:Molecular Marker [Clinical Attribute]

Phrase: "( x 174/HaeIII"

Phrase: ")."
Processing 00000000.tx.44: HC, healthy control; 

Phrase: "HC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020268:HC [Hormone,Pharmacologic Substance,Steroid]
  1000   C1413512:Hc [Gene or Genome]

Phrase: "healthy control"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C2986479:Healthy Control [Qualitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   789   C0018684:Health [Idea or Concept]
   789   C0031206:healthiness [Finding]

Phrase: ";"
Processing 00000000.tx.45: DC, disease control. 

Phrase: "DC,"

Phrase: "disease control."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C0920467:disease control [Therapeutic or Preventive Procedure]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.46: (B) Total protein lysates of lymphoblasts from the probands mother (lane 1) and the proband (lane 2) of pedigree A were immunoblotted with anti-TBP antibody (1TBP18; QED Bioscience). 

Phrase: "(B) Total protein lysates of lymphoblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1881488:Lysate [Physical Object]

Phrase: "from the probands mother"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0026591:Mother [Family Group]
   805 E C1826438:MATER [Gene or Genome]
   805 E C2347083:Maternal [Family Group]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the proband"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1948021:Proband [Family Group]
   944 E C0702110:Propositus [Organism Attribute]
   916 E C0702111:probands [Organism Attribute]

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "of pedigree A"

Phrase: "were"

Phrase: "immunoblotted with anti-TBP antibody"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   814   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774 E C0033618:Protein Binding [Molecular Function]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   714   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(1TBP18"

Phrase: "; QED Bioscience"

Phrase: ")."
Processing 00000000.tx.47: Only the proband has an abnormally large TBP. 

Phrase: "Only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the proband"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1948021:Proband [Family Group]
   944 E C0702110:Propositus [Organism Attribute]
   916 E C0702111:probands [Organism Attribute]

Phrase: "has"

Phrase: "an abnormally large TBP."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
Processing 00000000.tx.48: Because no lymphoblast cell line had been established, the probands sisters (pedigree A, III-2) lymphoblasts were not available.  

Phrase: "Because"

Phrase: "no lymphoblast cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0007600:Cell Line [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "had"

Phrase: "been"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: ","

Phrase: "the probands sisters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337514:Sisters [Family Group]

Phrase: "(pedigree A,"

Phrase: "III-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "lymphoblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0229613:Lymphoblasts [Cell]
  1000   C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: "were"

Phrase: "not available."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548671:Not available [Idea or Concept]
   861   C0470187:Available [Functional Concept]
Processing 00000000.tx.49: View larger version (90K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(90K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334335:90K [Gene or Genome]
  1000   C1705384:90K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.50: (A) Identification of TBP mutation in nine individuals from four independent Japanese pedigrees. 

Phrase: "(A) Identification of TBP mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]

Phrase: "in nine individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "from four independent Japanese pedigrees."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030761:pedigrees [Intellectual Product]
Processing 00000000.tx.51: Pedigree A has an obvious family history of spinocerebellar degeneration. 

Phrase: "Pedigree A"

Phrase: "has"

Phrase: "an obvious family history of spinocerebellar degeneration."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0241889:Family history [Finding]
   778   C1705495:Family History [Idea or Concept]
   769   C0004138:Spinocerebellar Degeneration, Familial [Disease or Syndrome]
   748   C0015576:Family [Family Group]
   748   C0019664:History [Occupation or Discipline]
   748   C0019665:history [Intellectual Product]
   748   C0262512:History, NOS [Organism Attribute]
   748   C0262926:History [Finding]
   748   C1704727:Family [Conceptual Entity]
   748   C1705255:History [Conceptual Entity]
   748   C2004062:History [Finding]
Processing 00000000.tx.52: We directly examined all the live members of pedigree B and found no neurological symptoms, except in III-2 who has a history of general convulsion. 

Phrase: "We directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "all the live members of pedigree B"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0680022:members [Population Group]
   714 E C2698041:Member [Professional or Occupational Group]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no neurological symptoms,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0235031:neurological symptoms [Sign or Symptom]
   861   C0683368:symptoms [Functional Concept]
   861   C1457887:Symptoms [Sign or Symptom]

Phrase: "except"

Phrase: "in III-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "who"

Phrase: "has"

Phrase: "a history of general convulsion."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0552478:History general [Organism Attribute]
   760   C0019664:History [Occupation or Discipline]
   760   C0019665:history [Intellectual Product]
   760   C0262512:History, NOS [Organism Attribute]
   760   C0262926:History [Finding]
   760   C1705255:History [Conceptual Entity]
   760   C2004062:History [Finding]
Processing 00000000.tx.53: In pedigree D, except for II-5, III-7 and III-8, there is no clinical information about the family members. 

Phrase: "In pedigree D,"

Phrase: "except for II-5,"

Phrase: "III-7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "and"

Phrase: "III-8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "there"

Phrase: "is"

Phrase: "no clinical information about the family members."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C2708732:Clinical information [Clinical Attribute]
   778   C2708733:Clinical information [Intellectual Product]
   774   C1546437:No Information [Qualitative Concept]
   774   C1549058:No Information [Idea or Concept]
   748   C1533716:Information [Idea or Concept]
Processing 00000000.tx.54: (B) Distribution of CAG number in the TATA-binding protein gene. 

Phrase: "(B) Distribution of CAG number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "in the TATA-binding protein gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.55: Totally, 748 chromosome analyses of the TBP locus were made on 116 control and 632 disease chromosomes. 

Phrase: "Totally,"

Phrase: "748 chromosome analyses of the TBP locus"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0200867:Chromosome analysis [Laboratory Procedure]
   745   C1514534:Protein Analysis [Molecular Biology Research Technique]
   712 E C0853259:chromosomal analysis [Laboratory Procedure]
   708   C0002778:Analysis [Laboratory Procedure]
   708   C0936012:Analysis [Research Activity]
   708   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "made on 116 control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C1881534:Make [Functional Concept]

Phrase: "and"

Phrase: "632 disease chromosomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008633:Chromosomes [Cell Component]
Processing 00000000.tx.56: The number of CAG/CAA repeats for the control chromosomes ranged from 29 to 42 (gray bars). 

Phrase: "The number of CAG/CAA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "repeats for the control chromosomes"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0008633:Chromosomes [Cell Component]
   760   C0205341:Repeat [Functional Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1547730:Repeat [Temporal Concept]
   760   C1550141:Control [Substance]
   760   C1705914:Repeat [Conceptual Entity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "ranged from 29"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "to 42"

Phrase: "(gray bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.57: Only one chromosome carrying a 42 CAG/CAA repeat was found (0.086%). 

Phrase: "Only one chromosome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008633:Chromosome [Cell Component]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "a 42 CAG/CAA repeat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205341:Repeat [Functional Concept]
   812   C1547730:Repeat [Temporal Concept]
   812   C1705914:Repeat [Conceptual Entity]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "(0.086%"

Phrase: ")."
Processing 00000000.tx.58: None of the control chromosomes had more than 43 CAG/CAA repeats, whereas in the disease group, seven chromosomes carried more than 43 CAG/CAA repeats (black bars). 

Phrase: "None of the control chromosomes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0008633:Chromosomes [Cell Component]
   760   C0243148:control [Qualitative Concept]
   760   C0456148:None [Quantitative Concept]
   760   C0549184:None [Quantitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "had"

Phrase: "more than 43 CAG/CAA repeats,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0205172:More [Functional Concept]
   753   C0205341:repeats [Functional Concept]
   753   C1705914:Repeats [Conceptual Entity]
   719 E C1547730:Repeat [Temporal Concept]

Phrase: "whereas in the disease group,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0012634:Disease [Disease or Syndrome]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "seven chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008633:Chromosomes [Cell Component]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "more than 43 CAG/CAA repeats"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0205172:More [Functional Concept]
   753   C0205341:repeats [Functional Concept]
   753   C1705914:Repeats [Conceptual Entity]
   719 E C1547730:Repeat [Temporal Concept]

Phrase: "(black bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.59: (C) There is a strong inverse correlation between age at onset and CAG number (R2 value = 0.783). 

Phrase: "(C) There"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "is"

Phrase: "a strong inverse correlation between age at onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "CAG number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "(R2 value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522609:Value [Quantitative Concept]

Phrase: "= 0.783"

Phrase: ")."
Processing 00000000.tx.60: The closed diamond at the 63 CAG repeat corresponds to the sporadic case of de novo mutation reported previously (14). 

Phrase: "The closed diamond at the 63 CAG repeat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0057717:Diamond [Element, Ion, or Isotope]
   744   C1706341:Diamond [Qualitative Concept]

Phrase: "corresponds to the sporadic case of de novo mutation"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C2985439:De novo mutation [Cell or Molecular Dysfunction]
   764   C1515568:de novo [Idea or Concept]
   742   C0011198:DE [Geographic Area]
   742   C0017480:DE [Geographic Area]
   742   C0026882:Mutation [Genetic Function]
   742   C0205422:Sporadic [Temporal Concept]
   742   C0868928:Case [Functional Concept]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]
   742   C1706255:CASE [Medical Device]
   742   C1706256:Case [Conceptual Entity]
   742   C3541240:DE [Idea or Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.61: (D) Polymorphic CAG/CAA sequences in the TBP genes of four probands and family members. 

Phrase: "("

Phrase: "D)"

Phrase: "Polymorphic CAG/CAA"

Phrase: "sequences in the TBP genes of four probands"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   809   C1337106:TATA Sequence-Binding Protein Gene [Gene or Genome]
   795   C0144555:TATA Sequence-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           TATA-Binding Protein
   760   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0002518:Protein Sequence [Amino Acid Sequence]
   757 E C0033618:Protein Binding [Molecular Function]
   743   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0004793:Sequence [Nucleotide Sequence]
   739   C0017337:Genes [Gene or Genome]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C0205450:Four [Quantitative Concept]
   739   C0243122:binding [Functional Concept]
   739   C0702111:probands [Organism Attribute]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1519249:Sequence [Functional Concept]
   706 E C1948021:Proband [Family Group]

Phrase: "and"

Phrase: "family members."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0086282:Family Members [Family Group]
   966 E C1611821:Family Member [Intellectual Product]
   861   C0015576:Family [Family Group]
   861   C0680022:members [Population Group]
   861   C1704727:Family [Conceptual Entity]
   827 E C2698041:Member [Professional or Occupational Group]
   789 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.62: Polymorphic regions in the TBP gene are divided into five lesions (15). 

Phrase: "Polymorphic regions in the TBP gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   750   C1514562:Protein Region [Amino Acid Sequence]
   744   C1882417:Polymorphic [Qualitative Concept]
   711   C0017446:Region [Geographic Area]
   711   C0205147:Region [Spatial Concept]

Phrase: "are"

Phrase: "divided into five lesions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205451:Five [Quantitative Concept]
   770   C0221198:lesions [Finding]
   770   C0332849:Divided [Functional Concept]
   737 E C1546698:Lesion [Intellectual Product]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.63: Roman numerals (IV) above the table denote the lesion domains. 

Phrase: "Roman numerals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439067:Roman numeral [Intellectual Product]
   827   C1720186:Numeral [Intellectual Product]

Phrase: "(IV) above the table"

Phrase: "denote"

Phrase: "the lesion domains."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.64: The disease phenotype is derived from the heterozygously expanded TBP allele and co-segregates with the abnormal expanded TBP allele, except in III-1 of pedigree B, who was asymptomatic at the time of our study.  

Phrase: "The disease phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is"

Phrase: "derived from the heterozygously expanded TBP allele"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762 E C0033618:Protein Binding [Molecular Function]
   742   C0002085:Allele [Gene or Genome]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205229:expanded [Spatial Concept]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1441547:Derived [Qualitative Concept]
   742   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "co-segregates with the abnormal expanded TBP allele,"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   782   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757 E C0033618:Protein Binding [Molecular Function]
   757   C0311448:Abnormal protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C2610644:CO binding [Molecular Function]
   739   C0002085:Allele [Gene or Genome]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205161:Abnormal [Qualitative Concept]
   739   C0205229:expanded [Spatial Concept]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C2347472:% Abnormal [Quantitative Concept]
   739   C2699333:ABNORMAL [Intellectual Product]

Phrase: "except"

Phrase: "in III-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "of pedigree B,"

Phrase: "who"

Phrase: "was"

Phrase: "asymptomatic at the time of our study."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0231221:Asymptomatic [Finding]
Processing 00000000.tx.65: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.66: SCA17 (TBP disease) clinical features  PCR screening of expanded CAG/CAA repeat in the TBP gene In pedigree A, the probands father showed dysarthria at the age of 26 and ataxic gait at the age of 34. 

Phrase: "SCA17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0144555:SCA17 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1705304:SCA17 [Gene or Genome]
  1000   C1846707:SCA17 [Disease or Syndrome]

Phrase: "(TBP disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0012634:Disease [Disease or Syndrome]
   756   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "clinical features  PCR screening of expanded CAG/CAA repeat"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0220908:Screening [Health Care Activity]
   742   C0220909:screening [Functional Concept]
   742   C1698960:screening [Intellectual Product]
   742   C1710031:Screening [Diagnostic Procedure]
   742   C1710477:SCREENING [Research Activity]

Phrase: "in the TBP gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "In pedigree A,"

Phrase: "the probands father"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015671:Father [Family Group]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "dysarthria at the age of 26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0013362:Dysarthria [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "ataxic gait at the age of 34."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0751837:Ataxic gait [Sign or Symptom]
   748   C0016928:Gait [Finding]
   748   C0234366:Ataxic [Sign or Symptom]
Processing 00000000.tx.67: He became bed-ridden at the age of 35 and died of pneumonia at the age of 37. 

Phrase: "He"

Phrase: "became"

Phrase: "bed-ridden at the age of 35"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0425251:Bed-ridden [Finding]
   748   C0004916:Bed [Manufactured Object]
   748   C0596170:BED [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "died of pneumonia"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0011065:Died [Organism Function]
   790   C0032285:Pneumonia [Disease or Syndrome]
   790   C1546956:Died [Finding]
   718 E C0231800:Expired [Organ or Tissue Function]
   718 E C1704631:Expire [Idea or Concept]

Phrase: "at the age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of 37."
Processing 00000000.tx.68: The disease phenotype in pedigree A, including the two affected siblings, is an autosomal dominantly inherited young-onset cerebellar ataxia and progressing dementia with the later addition of a pyramidal and an extrapyramidal sign, e.g. parkinsonism or trunkal dystonia. 

Phrase: "The disease phenotype in pedigree A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031437:Phenotype [Organism Attribute]
   753   C1285572:Phenotype [Laboratory Procedure]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the two affected siblings,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0037047:Siblings [Family Group]
   793 E C1611273:Sibling [Intellectual Product]

Phrase: "is"

Phrase: "an autosomal dominantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596142:autosomal [Cell Component]

Phrase: "inherited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:Inherited [Functional Concept]

Phrase: "young-onset cerebellar ataxia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0007758:Cerebellar Ataxia [Sign or Symptom]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   812   C1707522:Cerebellar [Tissue]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: "and"

Phrase: "progressing dementia with the later addition of a pyramidal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0011265:dementia [Mental or Behavioral Dysfunction]
   742   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "an extrapyramidal sign,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0234133:Extrapyramidal sign [Sign or Symptom]
   861   C0311392:Sign [Finding]
   861   C1547188:Sign [Idea or Concept]

Phrase: "e.g. parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "or"

Phrase: "trunkal dystonia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013421:Dystonia [Sign or Symptom]
   861   C0393593:Dystonia [Disease or Syndrome]
Processing 00000000.tx.69: This suggests that expansion of the CAG repeats of the TBP gene is associated with a new form of dominant SCA. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that expansion of the CAG"

Phrase: "repeats of the TBP gene"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   814   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774 E C0033618:Protein Binding [Molecular Function]
   748   C0017337:Gene [Gene or Genome]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205341:Repeat [Functional Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1547730:Repeat [Temporal Concept]
   748   C1705914:Repeat [Conceptual Entity]

Phrase: "is"

Phrase: "associated with a new form of dominant SCA."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   764   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   742   C0004134:Ataxia [Sign or Symptom]
   742   C0205314:New [Temporal Concept]
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1522492:Form [Functional Concept]
   742   C1527180:Dominant [Functional Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.70: To investigate this possibility, we screened 316 disease probands whose clinical phenotypes included hereditary spinocerebellar degeneration, sporadic spinocerebellar degeneration, multiple system atrophy, dementia of unknown etiology, chorea and spastic paraplegia. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "this possibility,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "we"

Phrase: "screened"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0220908:screen [Health Care Activity]
   966   C1305399:screen [Functional Concept]
   966   C1705053:Screen [Medical Device]

Phrase: "316 disease probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0702111:probands [Organism Attribute]
   793 E C1948021:Proband [Family Group]
   755 E C0702110:Propositus [Organism Attribute]

Phrase: "whose clinical phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031437:Phenotypes [Organism Attribute]
   827 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "hereditary spinocerebellar degeneration,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0004138:Spinocerebellar Degeneration, Hereditary [Disease or Syndrome]
   901   C0037952:Spino-Cerebellar Degeneration [Disease or Syndrome]
   901   C0087012:Spinocerebellar Degeneration [Disease or Syndrome]
   827   C0011164:Degeneration [Pathologic Function]
   827   C1880269:Degeneration [Functional Concept]

Phrase: "sporadic spinocerebellar degeneration,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0037952:Spino-Cerebellar Degeneration [Disease or Syndrome]
   901   C0087012:Spinocerebellar Degeneration [Disease or Syndrome]
   827   C0011164:Degeneration [Pathologic Function]
   827   C1880269:Degeneration [Functional Concept]

Phrase: "multiple system atrophy,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "dementia of unknown etiology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "chorea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008489:Chorea [Disease or Syndrome]

Phrase: "and"

Phrase: "spastic paraplegia."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0037772:Spastic Paraplegia [Disease or Syndrome]
   861   C0030486:Paraplegia [Disease or Syndrome]
   861   C0443306:Spastic [Sign or Symptom]
   789 E C0857021:Paraplegic [Finding]
Processing 00000000.tx.71: In all these cases, diseases in which the CAG expansions could be attributed to one of the previously identified genes were excluded. 

Phrase: "In all"

Phrase: "these cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "diseases in which"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0012634:Diseases [Disease or Syndrome]
   718 E C1836721:MALS [Finding]
   718 E C3538764:MALS [Gene or Genome]
   718 E C3540595:MAL [Gene or Genome]

Phrase: "the CAG expansions"

Phrase: "could"

Phrase: "be"

Phrase: "attributed to one of the previously identified genes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0017337:Genes [Gene or Genome]
   744   C0205396:Identified [Qualitative Concept]
   744   C0205447:One [Quantitative Concept]
   744   C1550043:Identified [Finding]
   744   C1551388:Identified [Functional Concept]
   711   C0449234:Attribute [Idea or Concept]
   711   C1704772:Attribute [Conceptual Entity]
   711   C1882133:Attribute [Qualitative Concept]

Phrase: "were"

Phrase: "excluded."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.72: The number of CAG/CAA repeats in the TBP gene ranged from 29 to 42 (including one chromosome of 42 repeats) in 116 healthy control chromosomes (Fig. 3B, gray bars). 

Phrase: "The number of CAG/CAA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "repeats in the TBP gene"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   814   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774 E C0033618:Protein Binding [Molecular Function]
   748   C0017337:Gene [Gene or Genome]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205341:Repeat [Functional Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1547730:Repeat [Temporal Concept]
   748   C1705914:Repeat [Conceptual Entity]

Phrase: "ranged from 29"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "to 42"

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "one chromosome of 42 repeats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0008633:Chromosome [Cell Component]

Phrase: ")"

Phrase: "in 116 healthy control chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0008633:Chromosomes [Cell Component]

Phrase: "(Fig. 3B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: "gray bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.73: The CAG repeat of the TBP gene has been intensively analyzed (13,14). 

Phrase: "The CAG repeat of the TBP gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0205341:Repeat [Functional Concept]
   742   C1547730:Repeat [Temporal Concept]
   742   C1705914:Repeat [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "intensively"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.74: In a large population study, alleles corresponding to a range of 2542 glutamine residues were detected, the most common alleles encoding stretches of 3239 glutamines. 

Phrase: "In a large population study,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0681876:Population Study [Research Activity]
   827   C0032659:Population [Quantitative Concept]
   827   C0557651:Study [Manufactured Object]
   827   C1257890:Population [Population Group]
   827   C2603343:Study [Research Activity]

Phrase: "alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Alleles [Gene or Genome]

Phrase: "corresponding to a range of 2542 glutamine residues"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C1514721:Range [Quantitative Concept]
   744   C2348147:Range [Quantitative Concept]
   744   C3542016:Range [Intellectual Product]
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "the most common alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Alleles [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "stretches of 3239 glutamines."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0270814:Stretches [Disease or Syndrome]
   737 E C0600080:stretch [Therapeutic or Preventive Procedure]
Processing 00000000.tx.75: A gln42 allele was found only once in 2003 chromosomes representing several different ethnic backgrounds (15). 

Phrase: "A gln42 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "once in 2003 chromosomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0008633:Chromosomes [Cell Component]
   770   C1720092:Once [Intellectual Product]
   770   C1948045:Once [Temporal Concept]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "several different ethnic backgrounds"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0015031:Ethnic background [Population Group]
           ETHNIC
   812   C0680174:ethnic [Finding]
   779   C1706907:Background [Conceptual Entity]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.76: We therefore concluded that a TBP gene having a CAG/CAA number in excess of 43 is pathological. 

Phrase: "We therefore"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "a TBP gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "having"

Phrase: "a CAG/CAA number in excess of 43"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]

Phrase: "is"

Phrase: "pathological."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0030664:Pathological [Biomedical Occupation or Discipline]
  1000   C1521733:Pathological [Functional Concept]
   928 E C0205469:pathology [Functional Concept]
   928 E C0677042:pathology [Pathologic Function]
Processing 00000000.tx.77: Our 316 disease cases provided three new probands (Fig. 3A, pedigrees B, C, D) whose CAG/CAA repeat number ranged from 47 to 48 (Fig. 3B, black bars; Table1). 

Phrase: "Our 316 disease cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "three new probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0702111:probands [Organism Attribute]
   793 E C1948021:Proband [Family Group]
   755 E C0702110:Propositus [Organism Attribute]

Phrase: "(Fig. 3A,"

Phrase: "pedigrees B,"

Phrase: "C,"

Phrase: "D)"

Phrase: "whose CAG/CAA repeat number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0237753:*Number [Quantitative Concept]
   812   C0449788:Number [Quantitative Concept]

Phrase: "ranged from 47"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "to 48"

Phrase: "(Fig. 3B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: "black bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "; Table1"

Phrase: ")."
Processing 00000000.tx.78: Therefore, 4346 CAG/CAA repeats might be intermediate alleles. 

Phrase: "Therefore,"

Phrase: "4346 CAG/CAA repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0205341:repeats [Functional Concept]
   812   C1705914:Repeats [Conceptual Entity]
   779 E C1547730:Repeat [Temporal Concept]

Phrase: "might"

Phrase: "be"

Phrase: "intermediate alleles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]
Processing 00000000.tx.79: The disease phenotype associated with CAG/CAA expansion in the TBP gene is complex and appears to be transmitted in a manner that defies easy categorization. 

Phrase: "The disease phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "associated with CAG/CAA expansion"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the TBP gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "transmitted in a manner"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0242781:Transmitted [Pathologic Function]
   770   C0332289:transmitted [Functional Concept]
   770   C1521797:Transmitted [Natural Phenomenon or Process]

Phrase: "that"

Phrase: "defies"

Phrase: "easy categorization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008902:categorization [Classification]
Processing 00000000.tx.80: In pedigrees A and B, the phenotype is transmitted autosomal dominantly, whereas in pedigree C, it seems to occur autosomal recessively. 

Phrase: "In pedigrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030761:pedigrees [Intellectual Product]

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is"

Phrase: "transmitted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0242781:Transmitted [Pathologic Function]
  1000   C0332289:transmitted [Functional Concept]
  1000   C1521797:Transmitted [Natural Phenomenon or Process]

Phrase: "autosomal dominantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596142:autosomal [Cell Component]

Phrase: "whereas in pedigree C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030761:Pedigree [Intellectual Product]

Phrase: "it"

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "autosomal recessively."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596142:autosomal [Cell Component]
Processing 00000000.tx.81: In addition, it seems to occur sporadically in pedigree D. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "it"

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "sporadically in pedigree D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030761:Pedigree [Intellectual Product]
Processing 00000000.tx.82: We therefore investigated the nucleotide sequence of the CAG/CAA repeat of the TBP loci of the family members in all the pedigrees to clarify the inheritance pattern of the expanded CAG repeat in the TBP gene. 

Phrase: "We therefore"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the nucleotide sequence of the CAG/CAA repeat"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   744   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C1519249:Sequence [Functional Concept]

Phrase: "of the TBP loci"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1708726:Locus [Gene or Genome]
   756   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of the family members"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0086282:Family Members [Family Group]
   966 E C1611821:Family Member [Intellectual Product]
   861   C0015576:Family [Family Group]
   861   C0680022:members [Population Group]
   861   C1704727:Family [Conceptual Entity]
   827 E C2698041:Member [Professional or Occupational Group]
   789 E C0241888:Familial [Functional Concept]

Phrase: "in all"

Phrase: "the pedigrees to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030761:pedigrees [Intellectual Product]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "the inheritance pattern of the expanded CAG repeat"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1136375:Pattern, Inheritance [Genetic Function]
   767   C1547394:Repeat pattern [Idea or Concept]
   767   C1547730:Repeat Pattern [Temporal Concept]
   744   C0449774:Pattern [Spatial Concept]

Phrase: "in the TBP gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.83: Both siblings (III-1 and III-2) in pedigree A have a heterozygous pattern of gln55 expansion expression at this site (Fig. 3D and Table 1). 

Phrase: "Both siblings"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037047:Siblings [Family Group]
   966 E C1611273:Sibling [Intellectual Product]

Phrase: "(III-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "and"

Phrase: "III-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "in pedigree A"

Phrase: "have"

Phrase: "a heterozygous pattern of gln55 expansion expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449774:Pattern [Spatial Concept]

Phrase: "at this site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "(Fig. 3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: "and"

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.84: Their healthy mother (pedigree A, II-9) has gln37/gln39 alleles. 

Phrase: "Their healthy mother"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0026591:Mother [Family Group]
   805 E C1826438:MATER [Gene or Genome]
   805 E C2347083:Maternal [Family Group]

Phrase: "(pedigree A,"

Phrase: "II-9"

Phrase: ")"

Phrase: "has"

Phrase: "gln37/gln39 alleles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Alleles [Gene or Genome]
Processing 00000000.tx.85: These findings indicate that the normal alleles of the proband and his sister were probably maternal transmissions, and the expanded gln55 alleles were paternal ones. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the normal alleles of the proband"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Alleles [Gene or Genome]

Phrase: "and"

Phrase: "his sister"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337514:Sister [Family Group]

Phrase: "were"

Phrase: "probably maternal transmissions,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C3274499:Maternal Transmission [Pathologic Function]
   793   C0040722:transmission [Idea or Concept]
   793   C0242781:Transmission [Pathologic Function]
   793   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "the expanded gln55 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Alleles [Gene or Genome]

Phrase: "were"

Phrase: "paternal ones."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205447:One [Quantitative Concept]
Processing 00000000.tx.86: Although it was not possible to study their fathers DNA, both the probands father and grandfather had a history of spinocerebellar degeneration. 

Phrase: "Although"

Phrase: "it"

Phrase: "was"

Phrase: "not possible to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332149:Possible [Qualitative Concept]
   827   C1518422:Not [Functional Concept]
   827   C1705910:Possible [Qualitative Concept]
   827   C2362652:Possible [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "their fathers DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "both"

Phrase: "the probands father"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015671:Father [Family Group]

Phrase: "and"

Phrase: "grandfather"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337475:Grandfather [Family Group]

Phrase: "had"

Phrase: "a history of spinocerebellar degeneration."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0019664:History [Occupation or Discipline]
   760   C0019665:history [Intellectual Product]
   760   C0262512:History, NOS [Organism Attribute]
   760   C0262926:History [Finding]
   760   C1705255:History [Conceptual Entity]
   760   C2004062:History [Finding]
Processing 00000000.tx.87: In pedigree B, the expanded gln47 allele of the proband was transmitted to both her daughters (III-1 and III-2). 

Phrase: "In pedigree B,"

Phrase: "the expanded gln47 allele of the proband"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "transmitted to both"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0242781:Transmitted [Pathologic Function]
   790   C0332289:transmitted [Functional Concept]
   790   C1521797:Transmitted [Natural Phenomenon or Process]

Phrase: "her daughters"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0011011:Daughters [Family Group]
   966 E C1610715:Daughter [Intellectual Product]

Phrase: "(III-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "and"

Phrase: "III-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.88: At the time of our study, the younger daughter of the 29-year-old had a history of general convulsion, and epilepsy was diagnosed based on her abnormal EEGs. 

Phrase: "At the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "of our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the younger daughter of the 29-year-old"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0011011:Daughter [Family Group]
   744   C1610715:Daughter [Intellectual Product]

Phrase: "had"

Phrase: "a history of general convulsion,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0552478:History general [Organism Attribute]
   760   C0019664:History [Occupation or Discipline]
   760   C0019665:history [Intellectual Product]
   760   C0262512:History, NOS [Organism Attribute]
   760   C0262926:History [Finding]
   760   C1705255:History [Conceptual Entity]
   760   C2004062:History [Finding]

Phrase: "and"

Phrase: "epilepsy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014544:Epilepsy [Disease or Syndrome]

Phrase: "was"

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "based on her abnormal EEGs."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0151611:Abnormal EEG [Finding]
   760   C0205161:Abnormal [Qualitative Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C2347472:% Abnormal [Quantitative Concept]
   760   C2699333:ABNORMAL [Intellectual Product]
   726 E C0002055:base [Inorganic Chemical]
   726   C0013819:EEG, NOS [Diagnostic Procedure]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.89: In contrast, the elder daughter at the age of 33 does not yet show any symptom of neurological deficit. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the elder daughter at the age of 33"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0011011:Daughter [Family Group]
   744   C1610715:Daughter [Intellectual Product]

Phrase: "does"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "any symptom of neurological deficit."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0235031:Neurological symptom [Sign or Symptom]
   760   C1457887:Symptom, NOS [Sign or Symptom]
Processing 00000000.tx.90: We speculate that she may be asymptomatic due to her young age, because our clinical observations show that this disease can have its onset as late as age 48. 

Phrase: "We"

Phrase: "speculate"

Phrase: "that"

Phrase: "she"

Phrase: "may"

Phrase: "be"

Phrase: "asymptomatic due to her young age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0231221:Asymptomatic [Finding]

Phrase: "because"

Phrase: "our clinical observations"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   983   C2986892:Clinical Observation [Idea or Concept]
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "this disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "can"

Phrase: "have"

Phrase: "its onset as late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332162:Onset [Qualitative Concept]

Phrase: "as age 48."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]
Processing 00000000.tx.91: We could not obtain any clinical information on the probands parents (II-1, II-8) in pedigree C, but all three manifesting siblings (III-3, III-5 and III-6) expressed abnormal gln48 alleles heterozygously, whereas the healthy siblings had only normal alleles. 

Phrase: "We"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "any clinical information on the probands parents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C2708732:Clinical information [Clinical Attribute]
   778   C2708733:Clinical information [Intellectual Product]
   748   C1533716:Information [Idea or Concept]

Phrase: "(II-1,"

Phrase: "II-8"

Phrase: ")"

Phrase: "in pedigree C,"

Phrase: "but"

Phrase: "all three manifesting siblings"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0037047:Siblings [Family Group]
   793 E C1611273:Sibling [Intellectual Product]

Phrase: "(III-3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "III-5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "and"

Phrase: "III-6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "expressed"

Phrase: "abnormal gln48 alleles heterozygously,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Alleles [Gene or Genome]

Phrase: "whereas"

Phrase: "the healthy siblings"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0037047:Siblings [Family Group]
   827 E C1611273:Sibling [Intellectual Product]

Phrase: "had"

Phrase: "only normal alleles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Alleles [Gene or Genome]
Processing 00000000.tx.92: In pedigree D, the proband (III-8) has gln32/gln47 alleles, whereas her healthy father (II-5) and brother (III-7) have only normal alleles. 

Phrase: "In pedigree D,"

Phrase: "the proband"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1948021:Proband [Family Group]
   944 E C0702110:Propositus [Organism Attribute]
   916 E C0702111:probands [Organism Attribute]

Phrase: "(III-8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "has"

Phrase: "gln32/gln47 alleles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Alleles [Gene or Genome]

Phrase: "whereas"

Phrase: "her healthy father"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015671:Father [Family Group]

Phrase: "(II-5"

Phrase: ")"

Phrase: "and"

Phrase: "brother"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337527:Brother [Family Group]

Phrase: "(III-7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "have"

Phrase: "only normal alleles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Alleles [Gene or Genome]
Processing 00000000.tx.93: No examination of the probands mother (II-3) could be made because she had died of breast cancer at the age of 43. 

Phrase: "No examination of the probands mother"

Phrase: "(II-3"

Phrase: ")"

Phrase: "could"

Phrase: "be"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "because"

Phrase: "she"

Phrase: "had"

Phrase: "died of breast cancer"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   881   C0006142:Cancer of Breast [Neoplastic Process]
           Breast Cancer
   881   C0678222:Cancer of Breast [Neoplastic Process]
           Breast Cancer
   783 E C0153661:thoracic cancer [Neoplastic Process]
   770   C0006141:Breast [Body Part, Organ, or Organ Component]
   770   C0006826:Cancer [Neoplastic Process]
   770   C0011065:Died [Organism Function]
   770   C0998265:Cancer [Eukaryote]
   770   C1268990:Breast [Body Part, Organ, or Organ Component]
   770   C1306459:Cancer [Finding]
   770   C1546956:Died [Finding]
   715 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   715 E C1521735:Pectoral [Qualitative Concept]

Phrase: "at the age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of 43."
Processing 00000000.tx.94: We also found two CAA/CAG expansion patterns by nucleotide sequencing of the TBP gene. 

Phrase: "We also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "two CAA/CAG expansion patterns by nucleotide sequencing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449774:Patterns [Spatial Concept]

Phrase: "of the TBP gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.95: One pattern is intragenomic partial duplication, as observed in patients III-1 and III-2 in pedigree A. 

Phrase: "One pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Pattern [Spatial Concept]

Phrase: "is"

Phrase: "intragenomic partial duplication,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332597:Duplication [Functional Concept]
   827   C1705960:Duplication [Cell or Molecular Dysfunction]

Phrase: "as"

Phrase: "observed in patients III-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0439070:III [Intellectual Product]
   760   C1441672:Observed [Functional Concept]
   760   C1705160:III [Qualitative Concept]

Phrase: "and"

Phrase: "III-2 in pedigree A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030761:Pedigree [Intellectual Product]
   760   C0439070:III [Intellectual Product]
   760   C1705160:III [Qualitative Concept]
Processing 00000000.tx.96: The other, which is most frequently seen in this disease, is the simple (CAG)y expansion in lesion IV of the TBP gene (Fig. 4D). 

Phrase: "The"

Phrase: "other,"

Phrase: "which"

Phrase: "is"

Phrase: "most frequently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205393:Most [Quantitative Concept]
   861   C0332183:Frequently [Temporal Concept]

Phrase: "seen in this disease,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "the simple"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205352:Simple [Qualitative Concept]

Phrase: "(CAG)y expansion in lesion IV"

Phrase: "of the TBP gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450377:4d [Intellectual Product]
   861   C2986754:4D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.97: View larger version (179K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(179K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.98: Brain MRI images of a representative patient (pedigree A, III-1) showing diffuse cortical and cerebellar atrophy. 

Phrase: "Brain MRI images of a representative patient"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1704254:Image [Intellectual Product]
   714   C1704922:Image [Entity]
   714   C3542466:Image [Intellectual Product]

Phrase: "(pedigree A,"

Phrase: "III-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "diffuse cortical"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0001613:Cortical [Body Part, Organ, or Organ Component]
   861   C0007776:Cortical [Body Part, Organ, or Organ Component]
   861   C0022655:Cortical [Body Part, Organ, or Organ Component]
   805 E C0234875:bark [Organism Attribute]
   805 E C2700441:Bark [Plant]
   777 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   777 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "cerebellar atrophy."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0740279:Cerebellar atrophy [Disease or Syndrome]
   861   C0333641:Atrophy [Pathologic Function]
   789 E C0151514:Atrophic [Disease or Syndrome]
Processing 00000000.tx.99: Atrophy between the cerebellar hemisphere, brain stem and cortex is not disproportionate. 

Phrase: "Atrophy between the cerebellar hemisphere,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0740279:Cerebellar atrophy [Disease or Syndrome]
   760   C0333641:Atrophy [Pathologic Function]

Phrase: "brain stem"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
  1000   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0242767:Stem [Plant]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "is"

Phrase: "not disproportionate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205350:Disproportionate [Qualitative Concept]
Processing 00000000.tx.100: T1-weighted axial images (A, B, C) and a T1-weighted sagital image (D).  

Phrase: "T1-weighted axial images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1704254:Image [Intellectual Product]
   779   C1704922:Image [Entity]
   779   C3542466:Image [Intellectual Product]

Phrase: "(A,"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "a T1-weighted sagital image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1704254:Image [Intellectual Product]
   812   C1704922:Image [Entity]
   812   C3542466:Image [Intellectual Product]

Phrase: "("

Phrase: "D)."
Processing 00000000.tx.101: Clinical features of SCA17 (TBP disease) Age at onset ranged from 19 to 48 years, mean age 33.2 years (n = 6, Table 1). 

Phrase: "Clinical features of SCA17"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C1521970:Feature [Qualitative Concept]
   737   C1706388:Feature [Conceptual Entity]
   737   C2346469:Feature [Qualitative Concept]
   737   C2348519:Feature [Qualitative Concept]

Phrase: "(TBP disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0012634:Disease [Disease or Syndrome]
   756   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "Age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]

Phrase: "ranged from 19"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "to 48 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "mean age 33.2 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   875   C1510829:Age-Years [Temporal Concept]
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "(n = 6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.102: There was a strong inverse correlation (R=0.88) between age at onset and the number of CAG repeats in the TBP gene (Fig. 3C) inspite of the narrow range of expanded alleles (4755 repeats) and difficulty in determining the exact age of the first sign of ataxia, bradykinesia or dementia in this disorder. 

Phrase: "There"

Phrase: "was"

Phrase: "a strong inverse correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707520:Correlation [Qualitative Concept]

Phrase: "(R=0.88"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: "between age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "the number of CAG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "repeats in the TBP gene"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   814   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774 E C0033618:Protein Binding [Molecular Function]
   748   C0017337:Gene [Gene or Genome]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205341:Repeat [Functional Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1547730:Repeat [Temporal Concept]
   748   C1705914:Repeat [Conceptual Entity]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")"

Phrase: "inspite of the narrow range of expanded alleles"

Phrase: "(4755 repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205341:repeats [Functional Concept]
   861   C1705914:Repeats [Conceptual Entity]
   827 E C1547730:Repeat [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "difficulty in determining"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1299586:Difficulty [Finding]
   718 E C0332218:Difficult [Qualitative Concept]

Phrase: "the exact age of the first sign of ataxia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0001779:Age [Organism Attribute]

Phrase: "bradykinesia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0233565:Bradykinesia [Sign or Symptom]

Phrase: "or"

Phrase: "dementia in this disorder."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0497327:dementia disorder [Mental or Behavioral Dysfunction]
           Dementia
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.103: Most individuals presented in the third decade with gait ataxia and dementia, progressing over several decades to include bradykinesia, dysmetria, dysdiadokokinesis, hyper-reflexia and paucity of movement. 

Phrase: "Most individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "presented in the third decade"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205437:Third [Quantitative Concept]
   760   C0449450:Presented [Idea or Concept]
   760   C2981279:Decade [Quantitative Concept]
   726 E C0150312:Present [Quantitative Concept]

Phrase: "with gait ataxia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0751837:Gait Ataxia [Sign or Symptom]
   861   C0004134:Ataxia [Sign or Symptom]
   789 E C0234366:Ataxic [Sign or Symptom]

Phrase: "and"

Phrase: "dementia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "progressing over several decades to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   797   C0205329:Progressing to [Functional Concept]
           progressing
   726 E C1272688:progress [Functional Concept]
   726 E C1280477:Progress [Functional Concept]
   726   C2981279:Decade [Quantitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "bradykinesia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0233565:Bradykinesia [Sign or Symptom]

Phrase: "dysmetria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234162:Dysmetria [Finding]

Phrase: "dysdiadokokinesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234979:Dysdiadochokinesia [Sign or Symptom]

Phrase: "hyper-reflexia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0151889:Hyperreflexia [Finding]
   916 E C2939158:Hyperreflexic [Qualitative Concept]
   861   C0424295:HYPER [Finding]

Phrase: "and"

Phrase: "paucity of movement."
Processing 00000000.tx.104: The first symptom (e.g. ataxia, dementia or parkinsonism) varied with the patient. 

Phrase: "The first symptom"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1457887:Symptom, NOS [Sign or Symptom]

Phrase: "("

Phrase: "e.g. ataxia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004134:Ataxia [Sign or Symptom]
   928 E C0234366:Ataxic [Sign or Symptom]

Phrase: "dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "or"

Phrase: "parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: ")"

Phrase: "varied with the patient."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:*^patient [Patient or Disabled Group]
Processing 00000000.tx.105: Parkinsonism in these cases mainly showed bradykinesia, gait disturbance (accelerated gait and marche  petits pas) and postural reflex disturbance (retropulsion), tremor and muscle rigidity being less prominent. 

Phrase: "Parkinsonism in these cases mainly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "bradykinesia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0233565:Bradykinesia [Sign or Symptom]

Phrase: "gait disturbance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0575081:Gait disturbance [Sign or Symptom]
   861   C2699787:Disturbance [Qualitative Concept]

Phrase: "(accelerated gait"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016928:Gait [Finding]

Phrase: "and"

Phrase: "marche  petits pas)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030125:PAS [Organic Chemical,Pharmacologic Substance]
   827   C1820373:PAS [Cell Component]

Phrase: "and"

Phrase: "postural reflex disturbance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2699787:Disturbance [Qualitative Concept]
   734   C0234154:Postural reflex [Organ or Tissue Function]

Phrase: "(retropulsion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0277845:Retropulsion [Sign or Symptom]

Phrase: ")"

Phrase: ","

Phrase: "tremor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040822:Tremor [Sign or Symptom]
  1000   C1963252:Tremor [Finding]

Phrase: "and"

Phrase: "muscle rigidity"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0026837:Muscle Rigidity [Sign or Symptom]
           Rigidity, NOS
   861   C0026845:Muscle [Tissue]
   861   C0700109:rigidity [Natural Phenomenon or Process]
   789 E C0231517:Rigid [Individual Behavior]
   789 E C0442025:Muscular [Spatial Concept]
   789 E C1882952:RIGID [Phenomenon or Process]

Phrase: "being"

Phrase: "less prominent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205402:Prominent [Qualitative Concept]
Processing 00000000.tx.106: The appearance of epilepsy varied, showing first as a neurological symptom in patient III-2 in pedigree B, but appearing in the late stage in patients III-6 in pedigree C and III-8 in pedigree D. 

Phrase: "The appearance of epilepsy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0233426:Appearance [Organism Attribute]
   770   C0700364:Appearance [Qualitative Concept]

Phrase: "varied"

Phrase: ","

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "first as a neurological symptom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]

Phrase: "in patient III-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:*^patient [Patient or Disabled Group]
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]

Phrase: "in pedigree B,"

Phrase: "but"

Phrase: "appearing in the late stage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0700364:APPEAR [Qualitative Concept]

Phrase: "in patients III-6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]

Phrase: "in pedigree C"

Phrase: "and"

Phrase: "III-8 in pedigree D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030761:Pedigree [Intellectual Product]
   760   C0439070:III [Intellectual Product]
   760   C1705160:III [Qualitative Concept]
Processing 00000000.tx.107: No abnormal eye movements were present in any patient. 

Phrase: "No abnormal eye movements"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0497202:Abnormal eye movement [Finding]
   981 E C1855559:Abnormal ocular movements [Finding]
   913   C0013384:Abnormal Movements [Disease or Syndrome]
   913   C0558189:Abnormal movement [Finding]
   901   C0015413:Eye Movements [Organ or Tissue Function]
   901   C0702182:eye movement [Finding]
   827   C0026649:Movement [Organism Function]

Phrase: "were"

Phrase: "present in any patient."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
Processing 00000000.tx.108: MRI or CT findings for all the patients indicated diffuse cortical and cerebellar atrophy (Fig. 4). 

Phrase: "MRI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024485:MRI [Diagnostic Procedure]
  1000   C1824234:MRI [Gene or Genome]

Phrase: "or"

Phrase: "CT findings for all"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3539655:Findings [Intellectual Product]
   737 E C0037088:Finding [Sign or Symptom]
   737 E C0243095:Finding [Finding]
   737 E C2825141:Finding [Finding]

Phrase: "the patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "diffuse cortical"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0001613:Cortical [Body Part, Organ, or Organ Component]
   861   C0007776:Cortical [Body Part, Organ, or Organ Component]
   861   C0022655:Cortical [Body Part, Organ, or Organ Component]
   805 E C0234875:bark [Organism Attribute]
   805 E C2700441:Bark [Plant]
   777 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   777 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "cerebellar atrophy"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0740279:Cerebellar atrophy [Disease or Syndrome]
   861   C0333641:Atrophy [Pathologic Function]
   789 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.109: Initial clinical diagnoses varied: dementia-related atypical Holmes type spinocerebellar degeneration (pedigree A), DRPLA-like spinocerebellar degeneration (pedigree B), atypical HD (pedigree C) and atypical parkinsonism with progressive dementia (pedigree D). 

Phrase: "Initial clinical diagnoses"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   867   C0332140:Diagnosis, clinical [Qualitative Concept]
   827   C0011900:Diagnoses [Finding]
   827   C0205210:Clinical [Qualitative Concept]
   793 E C1704338:diagnosis [Qualitative Concept]
   793 E C1704656:DIAGNOSIS [Research Activity]

Phrase: "varied"

Phrase: ":"

Phrase: "dementia-related atypical Holmes type spinocerebellar degeneration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C0037952:Spino-Cerebellar Degeneration [Disease or Syndrome]
   818   C0087012:Spinocerebellar Degeneration [Disease or Syndrome]
   795   C0011164:Degeneration [Pathologic Function]
   795   C1880269:Degeneration [Functional Concept]

Phrase: "(pedigree A"

Phrase: ")"

Phrase: ","

Phrase: "DRPLA-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0393578:Pallidoluysian atrophy [Disease or Syndrome]
   812   C0333641:Atrophy [Pathologic Function]
   741 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "like spinocerebellar degeneration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0037952:Spino-Cerebellar Degeneration [Disease or Syndrome]
  1000   C0087012:Spinocerebellar Degeneration [Disease or Syndrome]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: "(pedigree B"

Phrase: ")"

Phrase: ","

Phrase: "atypical HD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0020179:Huntington Disease [Disease or Syndrome]
   901   C2919056:Huntington's Disease [Functional Concept]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(pedigree"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030761:Pedigree [Intellectual Product]

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "atypical parkinsonism with progressive dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   835   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   760   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "(pedigree"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030761:Pedigree [Intellectual Product]

Phrase: "D)."
Processing 00000000.tx.110: Immunocytochemical study of postmortem brain tissues We conducted an immunocytochemical examination of postmortem brain tissues from a patient (pedigree C, III-5) who had expanded polyglutamine repeats (48) of his TBP. 

Phrase: "Immunocytochemical study of postmortem brain tissues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0683946:post-mortem study [Research Activity]
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "We"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "an immunocytochemical examination of postmortem brain tissues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0004398:Post-Mortem Examination [Diagnostic Procedure]
   774   C0555351:Brain examination [Diagnostic Procedure]

Phrase: "from a patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "(pedigree C,"

Phrase: "III-5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "who"

Phrase: "had"

Phrase: "expanded polyglutamine repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205341:repeats [Functional Concept]
   827   C1705914:Repeats [Conceptual Entity]
   793 E C1547730:Repeat [Temporal Concept]

Phrase: "(48"

Phrase: ")"

Phrase: "of his TBP."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
Processing 00000000.tx.111: A conventional neuropathological examination revealed shrinkage and moderate loss of small neurons with gliosis in the caudate nucleus and putamen. 

Phrase: "A conventional neuropathological examination"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "shrinkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332513:Shrinkage [Functional Concept]

Phrase: "and"

Phrase: "moderate loss of small neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   844   C0598940:Loss of neurons [Finding]
           neuron loss
   760   C1517945:Loss [Quantitative Concept]
   756 E C1850496:Neuronal loss [Finding]

Phrase: "with gliosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017639:Gliosis [Pathologic Function]

Phrase: "in the caudate nucleus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007461:Caudate Nucleus [Body Part, Organ, or Organ Component]
  1000   C1269580:Caudate nucleus [Body Part, Organ, or Organ Component]
   861   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: "putamen."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034169:Putamen [Body Part, Organ, or Organ Component]
  1000   C1281335:Putamen [Body Part, Organ, or Organ Component]
Processing 00000000.tx.112: Large neurons were relatively preserved. 

Phrase: "Large neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0228072:Large neuron [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "relatively"

Phrase: "preserved."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033085:Preserved [Laboratory Procedure]
Processing 00000000.tx.113: Similar but moderate changes were detected in the thalamus, frontal cortex and temporal cortex. 

Phrase: "Similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "but"

Phrase: "moderate changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "detected in the thalamus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039729:Thalamus [Body Part, Organ, or Organ Component]
   770   C0442726:Detected [Finding]
   770   C1269896:Thalamus [Body Part, Organ, or Organ Component]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "frontal cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0205123:Frontal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "temporal cortex."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0442043:Temporal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2362314:Temporal [Temporal Concept]
   861   C2700441:Cortex [Plant]
Processing 00000000.tx.114: Moderate Purkinje cell loss and an increase of Bergmann glia were seen in the cerebellum. 

Phrase: "Moderate Purkinje cell loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "an increase of Bergmann glia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "were"

Phrase: "seen in the cerebellum."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   770   C0205397:Seen [Qualitative Concept]
   770   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   770   C1707522:Cerebellum [Tissue]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]
Processing 00000000.tx.115: Torpedoes were occasionally encountered. 

Phrase: "Torpedoes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040478:Torpedo [Fish]

Phrase: "were"

Phrase: "occasionally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Occasionally [Temporal Concept]

Phrase: "encountered."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0545082:Encounter [Behavior]
   966   C1512346:encounter [Health Care Activity]
   966   C1947978:Encounter [Behavior]
Processing 00000000.tx.116: Immunocytochemical analysis performed with anti-ubiquitin (Fig.5B and H) and anti-TBP (Fig. 5D and K) antibodies showed neuronal intranuclear inclusion bodies (NIIs). 

Phrase: "Immunocytochemical analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "performed with anti-ubiquitin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Fig.5B"

Phrase: "and"

Phrase: "H)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "anti-TBP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "(Fig. 5D"

Phrase: "and"

Phrase: "K) antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C0313239:K Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   983   C0313240:k Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "neuronal intranuclear inclusion bodies (NIIs)."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   923   C1366904:Intranuclear Inclusion Bodies [Cell Component]
   861   C0007637:Inclusion Bodies [Cell Component]
   858   C0230595:Intranuclear body [Cell Component]
   850   C0682679:neuron body [Cell Component]
   812   C0242821:bodies [Human]
   812   C1995017:Bodies [Cell Component]
   779 E C0460148:Body [Anatomical Structure]
   779 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.117: In addition, most, if not all, neuronal nuclei were diffusely stained with 1C2-Ab (Fig. 5C), whereas none were stained in the healthy control brains (Fig. 5E and F). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "most,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "if"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all,"

Phrase: "neuronal nuclei"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3146324:neuronal nuclei [Gene or Genome]
   827   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "diffusely"

Phrase: "stained with 1C2-Ab (Fig. 5C"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0349966:Fig [Food]
   753   C1337208:FIG [Food]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "none"

Phrase: "were"

Phrase: "stained in the healthy control brains"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   790   C2986479:Healthy Control [Qualitative Concept]
   783   C0596948:brains control [Mental Process]
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C2986582:Stained [Qualitative Concept]
   753   C3274648:Control [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 5E"

Phrase: "and"

Phrase: "F)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.118: Except for SCA2 (16,17) and SCA6 (18), in which abnormal inclusions are present in the cytoplasm, NIIs may provide a marker of disease process in many polyglutamine diseases (19,20). 

Phrase: "Except for SCA2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0752121:SCA2 [Disease or Syndrome]
  1000   C1334353:SCA-2 [Gene or Genome]
  1000   C1705387:SCA-2 [Gene or Genome]

Phrase: "(16,"

Phrase: "17"

Phrase: ")"

Phrase: "and"

Phrase: "SCA6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0752124:SCA6 [Disease or Syndrome]

Phrase: "(18"

Phrase: ")"

Phrase: ","

Phrase: "in which abnormal inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512693:Inclusion [Qualitative Concept]

Phrase: "are"

Phrase: "present in the cytoplasm,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "NIIs"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   923   C1366904:Intranuclear Inclusion Bodies [Cell Component]
   861   C0007637:Inclusion Bodies [Cell Component]
   858   C0230595:Intranuclear body [Cell Component]
   850   C0682679:neuron body [Cell Component]
   812   C0242821:bodies [Human]
   812   C1995017:Bodies [Cell Component]
   779 E C0460148:Body [Anatomical Structure]
   779 E C1268086:Body [Anatomical Structure]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a marker of disease process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1511983:Disease Marker [Idea or Concept]
   760   C0005516:Marker [Clinical Attribute]

Phrase: "in many polyglutamine diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "(19,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.119: The presence of NIIs in the brain of the patient who had expanded polyglutamine repeats (48) further confirmed that this disorder should be categorized as a polyglutamine disease. 

Phrase: "The presence of NIIs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of the patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "who"

Phrase: "had"

Phrase: "expanded polyglutamine repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205341:repeats [Functional Concept]
   827   C1705914:Repeats [Conceptual Entity]
   793 E C1547730:Repeat [Temporal Concept]

Phrase: "(48"

Phrase: ")"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "this disorder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorder [Disease or Syndrome]

Phrase: "should"

Phrase: "be"

Phrase: "categorized as a polyglutamine disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0012634:Disease [Disease or Syndrome]
   760   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   760   C0871968:categorized [Activity]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.120: View larger version (75K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(75K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.121: Immunohistochemical study of postmortem brain tissues from a patient (pedigree C, III-5). 

Phrase: "Immunohistochemical study of postmortem brain tissues"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0683946:post-mortem study [Research Activity]
   753   C0557651:Study [Manufactured Object]
   753   C1441616:Immunohistochemical [Laboratory Procedure]
   753   C2603343:Study [Research Activity]

Phrase: "from a patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "(pedigree C,"

Phrase: "III-5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.122: (A) A small neuron in the putamen has an intranuclear inclusion body (HE stain). 

Phrase: "(A)"

Phrase: "A small neuron in the putamen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0228075:Small neuron [Cell]
   753   C0027882:Neuron [Cell]

Phrase: "has"

Phrase: "an intranuclear inclusion body"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1366904:Intranuclear inclusion body [Cell Component]
           Intranuclear inclusion
   913   C0230595:Intranuclear body [Cell Component]
   901   C0007637:inclusion body [Cell Component]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]

Phrase: "("

Phrase: "HE"

Phrase: "stain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: ")."
Processing 00000000.tx.123: (B) Anti-ubiquitin antibody (Dakopatts; 

Phrase: "(B) Anti-ubiquitin antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0368720:B Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Dakopatts"

Phrase: ";"
Processing 00000000.tx.124: 1:1000): a positive intranuclear inclusion body identified in the putamen. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ")"

Phrase: ":"

Phrase: "a positive intranuclear inclusion body"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C1366904:Intranuclear inclusion body [Cell Component]
   875   C0230595:Intranuclear body [Cell Component]
   861   C0007637:inclusion body [Cell Component]
   812   C0242821:body [Human]
   812   C0460148:Body [Anatomical Structure]
   812   C1268086:Body [Anatomical Structure]
   729 E C1995017:Bodies [Cell Component]

Phrase: "identified in the putamen."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0034169:Putamen [Body Part, Organ, or Organ Component]
   770   C0205396:Identified [Qualitative Concept]
   770   C1281335:Putamen [Body Part, Organ, or Organ Component]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
Processing 00000000.tx.125: (C) Diffuse 1C2-Ab (Chemicon, 1:1000 dilution): immunoreactive neuronal nuclei scattered throughout the frontal cortex. 

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Diffuse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205219:Diffuse [Qualitative Concept]

Phrase: "1C2-Ab (Chemicon,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: ")"

Phrase: ":"

Phrase: "immunoreactive neuronal nuclei"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C3146324:neuronal nuclei [Gene or Genome]
   793   C0007610:Nucleus [Cell Component]

Phrase: "scattered throughout the frontal cortex."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   760   C0007776:Cortex [Body Part, Organ, or Organ Component]
   760   C0205123:Frontal [Spatial Concept]
   760   C0439742:Scattered [Spatial Concept]
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]
Processing 00000000.tx.126: In contrast, no 1C2-Ab immunoreactive neurons are present in the frontal cortex (E) or putamen (F) of a healthy control brain. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "no 1C2-Ab immunoreactive neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "are"

Phrase: "present in the frontal cortex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "(E)"

Phrase: "or"

Phrase: "putamen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034169:Putamen [Body Part, Organ, or Organ Component]
  1000   C1281335:Putamen [Body Part, Organ, or Organ Component]

Phrase: "(F) of a healthy control brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   753   C0439133:(f) [Intellectual Product]
   753   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.127: (D) The intranuclear inclusion body in a neuron of the putamen is also positive for anti-TBP antibody (QED Bioscience; 

Phrase: "("

Phrase: "D)"

Phrase: "The intranuclear inclusion body in a neuron of the putamen"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   782   C1366904:Intranuclear inclusion body [Cell Component]
   760   C0007637:inclusion body [Cell Component]
   757   C0230595:Intranuclear body [Cell Component]
   757   C0682679:neuron body [Cell Component]
   739   C0242821:body [Human]
   739   C0460148:Body [Anatomical Structure]
   739   C1268086:Body [Anatomical Structure]

Phrase: "is"

Phrase: "also positive for anti-TBP antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0741132:antibody positive [Laboratory or Test Result]
   744   C0439178:% Positive [Quantitative Concept]
   744   C1446409:Positive [Qualitative Concept]
   744   C1514241:Positive [Finding]
   744   C2825490:Positive [Qualitative Concept]

Phrase: "(QED Bioscience"

Phrase: ";"
Processing 00000000.tx.128: 1TBP18, 1:20000 dilution). 

Phrase: "1TBP18,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "20000 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: ")."
Processing 00000000.tx.129: An immunofluorescent double-labeling study of the neuronal intranuclear inclusion body (GI). 

Phrase: "An immunofluorescent double-labeling study of the neuronal intranuclear inclusion body"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0557651:Study [Manufactured Object]
   738   C2603343:Study [Research Activity]

Phrase: "(GI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539617:GI [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.130: NII in a neuron of the caudate nucleus (GI) and in a neuron of the putamen (JL). 

Phrase: "NII in a neuron of the caudate nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0683827:NII [Intellectual Product]

Phrase: "(GI)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539617:GI [Idea or Concept]

Phrase: "and in a neuron of the putamen"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0027882:Neuron [Cell]
   748   C0034169:Putamen [Body Part, Organ, or Organ Component]
   748   C1281335:Putamen [Body Part, Organ, or Organ Component]
   748   C1515981:And [Idea or Concept]

Phrase: "(JL"

Phrase: ")."
Processing 00000000.tx.131: Neurons are stained with monoclonal 1C2-Ab (red, G and J), anti-ubiquitin antibody (green, H) or anti-TBP polyclonal antibody (green, K; Santa Cruz, sc204). 

Phrase: "Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "are"

Phrase: "stained with monoclonal 1C2-Ab (red,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0332575:Red [Finding]
   753   C0746619:monoclonal [Finding]
   753   C1260956:Red [Qualitative Concept]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "J"

Phrase: ")"

Phrase: ","

Phrase: "anti-ubiquitin antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "H)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "or"

Phrase: "anti-TBP polyclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   895   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   839   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "; Santa Cruz,"

Phrase: "sc204"

Phrase: ")."
Processing 00000000.tx.132: This NII consists of an abnormal polyglutamine epitope and ubiquitin (merge, I). 

Phrase: "This NII"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683827:NII [Intellectual Product]

Phrase: "consists of an abnormal polyglutamine epitope"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0003316:Epitope [Immunologic Factor]
   753   C0205161:Abnormal [Qualitative Concept]
   753   C0332529:CONSIST [Qualitative Concept]
   753   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   753   C2347472:% Abnormal [Quantitative Concept]
   753   C2699333:ABNORMAL [Intellectual Product]

Phrase: "and"

Phrase: "ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "merge"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881786:Merge [Activity]

Phrase: ","

Phrase: "I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.133: It also has TBP (K). 

Phrase: "It also"

Phrase: "has"

Phrase: "TBP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "(K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.134: A Normarski view (blue channel) is superimposed on (JL). 

Phrase: "A Normarski view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449911:View [Spatial Concept]

Phrase: "(blue channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439799:Channel [Spatial Concept]
   861   C1706095:Channel [Conceptual Entity]

Phrase: ")"

Phrase: "is"

Phrase: "superimposed"

Phrase: "on (JL"

Phrase: ")."
Processing 00000000.tx.135: Scale bar: 10 m for (A, B, D, E, F, I, J) and 25 m for (C).   

Phrase: "Scale bar"

Phrase: ":"

Phrase: "10 m for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441923:M+ [Intellectual Product]

Phrase: "(A,"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "E,"

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "J)"

Phrase: "and"

Phrase: "25 m for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441923:M+ [Intellectual Product]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.136: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  TBP is an important general transcription initiation factor (15,21) and the DNA-binding subunit of RNA polymerase II transcription factor D (TFIID), the multi-subunit complex crucial for the expression of most genes (22,23). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TBP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "an important general transcription initiation factor"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   888   C1135650:General Transcription Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1158830:Transcription Initiation [Genetic Function]
           Initiation
   804   C0040649:Transcription [Genetic Function]
   804   C0589507:Initiation [Mental Process]
   804   C1521761:Factor [Functional Concept]
   804   C1704686:Initiation [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]

Phrase: "(15,"

Phrase: "21"

Phrase: ")"

Phrase: "and"

Phrase: "the DNA-binding subunit of RNA polymerase II transcription factor"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   851   C3158311:RNA polymerase II transcription factor binding [Genetic Function]
   777   C0012889:DNA Polymerase II [Amino Acid, Peptide, or Protein,Enzyme]
   777   C1149367:transcription factor binding [Genetic Function]
   777   C2257058:DNA polymerase II [Genetic Function]
   777   C2610704:RNA polymerase binding [Molecular Function]
   775   C2610838:DNA polymerase binding [Molecular Function]
   760   C1148673:DNA Binding [Genetic Function]
   757   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   757   C1148846:RNA Binding [Genetic Function]
   739   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1711351:Subunit [Quantitative Concept]

Phrase: "D ("

Phrase: "TFIID"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0076919:TFIID [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1337106:TFIID [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "the multi-subunit complex crucial for the expression of most genes"

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.137: The long polyglutamine domain is located in the N-terminus of TBP which regulates the DNA-binding activity of the C-terminus of the protein (24,25). 

Phrase: "The long polyglutamine domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "located in the N-terminus of TBP"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   804   C1323338:protein N-terminus binding [Molecular Function]
   790   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762 E C0033618:Protein Binding [Molecular Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]

Phrase: "which"

Phrase: "regulates"

Phrase: "the DNA-binding activity of the C-terminus of the protein"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C3642159:Protein C Activity [Laboratory Procedure]
   756   C2266866:Binding Activity [Molecular Function]
   754   C1537044:protein activity [Molecular Function]
   738   C0205177:Activity [Functional Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C1561536:*Activity [Idea or Concept]

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.138: Imbert et al. 

Phrase: "Imbert et al."
Processing 00000000.tx.139: (26) first suggested the possibility of a role for this N-terminal expanded CAG repeat of TBP in certain late-onset neurologic disorders. 

Phrase: "(26"

Phrase: ")"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the possibility of a role"

Phrase: "for this N-terminal expanded CAG repeat"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0039551:Terminal Repeat [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0205341:Repeat [Functional Concept]
   804   C1547730:Repeat [Temporal Concept]
   804   C1705914:Repeat [Conceptual Entity]

Phrase: "of TBP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "in certain late-onset neurologic disorders."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   888   C0376415:Late-Onset Disorders [Disease or Syndrome]
   840   C0027765:Neurologic Disorders [Disease or Syndrome]
   836   C0277793:onset disorder [Temporal Concept]
   804   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.140: Since then, this gene has been investigated intensively as a candidate for psychiatric disorders (13,26,27). 

Phrase: "Since then,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1711239:Since [Temporal Concept]
   861   C1883708:Then [Temporal Concept]

Phrase: "this gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "intensively as a candidate"

Phrase: "for psychiatric disorders"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0004936:Psychiatric disorders [Mental or Behavioral Dysfunction]
   861   C0012634:Disorders [Disease or Syndrome]
   861   C0205487:Psychiatric [Functional Concept]
   789 E C0033872:Psychiatry [Professional or Occupational Group]
   789 E C0033873:Psychiatry [Biomedical Occupation or Discipline]

Phrase: "(13,"

Phrase: "26,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.141: We show here for the first time that CAG expansion in the TBP gene does cause a neurological disorder inherited in an autosomal dominant manner that is classified as a novel polyglutamine disease. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "here for the first time"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "that CAG expansion in the TBP gene"

Phrase: "does"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a neurological disorder"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027765:Neurological disorder [Disease or Syndrome]
   861   C0012634:Disorder [Disease or Syndrome]

Phrase: "inherited in an autosomal dominant manner"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0443147:Autosomal dominant [Intellectual Product]
   753   C0439660:Inherited [Functional Concept]
   753   C0596142:autosomal [Cell Component]
   753   C1527180:Dominant [Functional Concept]

Phrase: "that"

Phrase: "is"

Phrase: "classified as a novel polyglutamine disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0008902:Classified [Classification]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0205314:Novel [Temporal Concept]
   753   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   753   C0679622:novel [Intellectual Product]
Processing 00000000.tx.142: Several lines of evidence support our conclusion that polyglutamine expansion in the TBP is pathogenic and the causative agent of a novel type of disease phenotype. 

Phrase: "Several lines of evidence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205132:lines [Spatial Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "our conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "that polyglutamine expansion in the TBP"

Phrase: "is"

Phrase: "pathogenic"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0450254:Pathogenic [Organism]
   928 E C0030657:pathogenicity [Qualitative Concept]
   928 E C1136169:Pathogenicity [Organism Attribute]

Phrase: "and"

Phrase: "the causative agent of a novel type of disease phenotype."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0449411:Causative agent [Finding]
   739   C0450442:Agent [Chemical Viewed Functionally]
   739   C1254351:Agent [Pharmacologic Substance]
   739   C1521826:Agent [Intellectual Product]
Processing 00000000.tx.143: (i) The disease phenotype completely co-segregates with the genotype of the abnormally expanded CAG/CAA repeat and arises from a heterozygously expanded TBP allele in all the patients in the four pedigrees we have examined. 

Phrase: "(i)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "The disease phenotype completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]

Phrase: "co-segregates with the genotype of the abnormally expanded CAG/CAA repeat"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   736   C0017431:Genotype [Organism Attribute]
   736   C0205229:expanded [Spatial Concept]
   736   C0205341:Repeat [Functional Concept]
   736   C1547730:Repeat [Temporal Concept]
   736   C1705914:Repeat [Conceptual Entity]

Phrase: "and"

Phrase: "arises from a heterozygously expanded TBP allele"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762 E C0033618:Protein Binding [Molecular Function]
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   742   C0002085:Allele [Gene or Genome]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205229:expanded [Spatial Concept]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]

Phrase: "in all"

Phrase: "the patients in the four pedigrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: "we"

Phrase: "have"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.144: (ii) The clinical features of young-onset ataxia, dementia and parkinsonism are very common. 

Phrase: "(ii"

Phrase: ")"

Phrase: "The clinical features of young-onset ataxia,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   714   C1521970:Feature [Qualitative Concept]
   714   C1706388:Feature [Conceptual Entity]
   714   C2346469:Feature [Qualitative Concept]
   714   C2348519:Feature [Qualitative Concept]

Phrase: "dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "are"

Phrase: "very common."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205214:Common [Quantitative Concept]
   861   C1522138:Common [Functional Concept]
   861   C3245511:common [Intellectual Product]
Processing 00000000.tx.145: (iii) The disease phenotype detected in this study shares a feature (very common ) with a case of de novo TBP mutation (14), whereas the clinical feature appears to be more complex and severer in a sporadic case (63 CAG repeats). 

Phrase: "(iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "The disease phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "detected in this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442726:Detected [Finding]
   770   C0557651:Study [Manufactured Object]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C2603343:Study [Research Activity]

Phrase: "shares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "a feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1521970:Feature [Qualitative Concept]
  1000   C1706388:Feature [Conceptual Entity]
  1000   C2346469:Feature [Qualitative Concept]
  1000   C2348519:Feature [Qualitative Concept]

Phrase: "(very common"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205214:Common [Quantitative Concept]
   861   C1522138:Common [Functional Concept]
   861   C3245511:common [Intellectual Product]

Phrase: ")"

Phrase: "with a case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of de novo TBP mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   904   C2985439:De novo mutation [Cell or Molecular Dysfunction]
   799   C0026882:Mutation [Genetic Function]
   799   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the clinical feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1521970:Feature [Qualitative Concept]
   861   C1706388:Feature [Conceptual Entity]
   861   C2346469:Feature [Qualitative Concept]
   861   C2348519:Feature [Qualitative Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "more complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "severer in a sporadic case"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0205082:Severe [Qualitative Concept]

Phrase: "(63 CAG repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205341:repeats [Functional Concept]
   827   C1705914:Repeats [Conceptual Entity]
   793 E C1547730:Repeat [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.146: (iv) Except for one previously reported case (14), there has been no report of a CAG expansion of more than 43 repeats. 

Phrase: "(iv) Except for one previously reported case"

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "there"

Phrase: "has"

Phrase: "been"

Phrase: "no report of a CAG expansion of more"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0684224:Report [Intellectual Product]
   744   C0700287:Report [Health Care Activity]
   744   C3273238:Report [Intellectual Product]

Phrase: "than 43 repeats."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205341:repeats [Functional Concept]
   861   C1705914:Repeats [Conceptual Entity]
   827 E C1547730:Repeat [Temporal Concept]
Processing 00000000.tx.147: (v) We found a strong negative correlation between age at onset and the number of polyglutamine repeats (R2 value = 0.78), a correlation frequently found in other polyglutamine disorders. 

Phrase: "(v)"

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "a strong negative correlation between age at onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "the number of polyglutamine repeats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "(R2 value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522609:Value [Quantitative Concept]

Phrase: "= 0.78"

Phrase: ")"

Phrase: ","

Phrase: "a correlation frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707520:Correlation [Qualitative Concept]

Phrase: "found in other polyglutamine disorders."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0012634:Disorders [Disease or Syndrome]
   760   C0150312:Found [Quantitative Concept]
   760   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   726 E C0243095:Find [Finding]
Processing 00000000.tx.148: (vi) NII bodies were present in a diseased brain which carried 48 CAG repeats. 

Phrase: "(vi) NII bodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0242821:bodies [Human]
   827   C1995017:Bodies [Cell Component]
   793 E C0460148:Body [Anatomical Structure]
   793 E C1268086:Body [Anatomical Structure]

Phrase: "were"

Phrase: "present in a diseased brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "which"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "48 CAG repeats."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205341:repeats [Functional Concept]
   827   C1705914:Repeats [Conceptual Entity]
   793 E C1547730:Repeat [Temporal Concept]
Processing 00000000.tx.149: We found no evidence, however, indicative of the instability of the CAG repeat in germline transmission, a characteristic feature of polyglutamine diseases. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no evidence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "however,"

Phrase: "indicative of the instability of the CAG repeat"

Phrase: "in germline transmission,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040722:transmission [Idea or Concept]
   861   C0242781:Transmission [Pathologic Function]
   861   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "a characteristic feature of polyglutamine diseases."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1521970:Feature [Qualitative Concept]
   753   C1706388:Feature [Conceptual Entity]
   753   C2346469:Feature [Qualitative Concept]
   753   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.150: The precise molecular mechanism that operates in the present disease is not clear. 

Phrase: "The precise molecular mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "operates in the present disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0012634:Disease [Disease or Syndrome]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C3242339:operate [Functional Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.151: Nuclear localization of the protein with the expanded polyglutamine tract, however, has been indicated as crucial to polyglutamine disease pathogenesis (8,2830). 

Phrase: "Nuclear localization of the protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0597704:protein localisation [Cell Function]
   797   C1159772:Protein Localization [Cell Function]
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "with the expanded polyglutamine tract,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1185740:Tract [Body Part, Organ, or Organ Component]

Phrase: "however,"

Phrase: "has"

Phrase: "been"

Phrase: "indicated as crucial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1444656:Indicated [Finding]

Phrase: "to polyglutamine disease pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0543483:pathogenesis [Functional Concept]
   827   C0699748:Pathogenesis [Pathologic Function]

Phrase: "(8,"

Phrase: "2830"

Phrase: ")."
Processing 00000000.tx.152: Of the eight known causative genes of polyglutamine diseases, TBP is the third gene, along with the androgen receptor and CACNL1A4 (the genes responsible for SBMA and SCA6, respectively), whose function is well understood. 

Phrase: "Of the eight known causative genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Genes [Gene or Genome]

Phrase: "of polyglutamine diseases,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "TBP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "the third gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "along with the androgen receptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0002844:Androgen [Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C3536949:Androgen [Pharmacologic Substance]

Phrase: "and"

Phrase: "CACNL1A4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1456413:CACNL1A4 [Gene or Genome]

Phrase: "("

Phrase: "the genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "responsible for SBMA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "SCA6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0752124:SCA6 [Disease or Syndrome]

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "whose"

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "well understood."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]
   827   C0162340:Understand [Mental Process]
Processing 00000000.tx.153: Taking into account the fact that TBP is abundant in the nucleus and is essential for gene expression, its participation in polyglutamine diseases favors a molecular pathogenesis for these diseases. 

Phrase: "Taking into"

Phrase: "account"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1551359:account [Idea or Concept]
  1000   C2741673:Account # [Clinical Attribute]
  1000   C2981730:Account [Classification]

Phrase: "the fact"

Phrase: "that TBP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "abundant in the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2346714:Abundant [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "essential for gene expression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0600449:Gene, Essential [Gene or Genome]
   770   C0205224:Essential [Qualitative Concept]

Phrase: "its participation in polyglutamine diseases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0679823:Participation [Functional Concept]

Phrase: "favors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "a molecular pathogenesis for these diseases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0543483:pathogenesis [Functional Concept]
   753   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.154: When bound to the TATA box, TBP has a saddle-like shape with its concave face contacting the DNA and its convex one interacting with the other TFIID subunits, the TBP-associated factors (TAFs) (23). 

Phrase: "When"

Phrase: "bound to the TATA box,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0080206:TATA Box [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0179400:Box [Manufactured Object]
   760   C0332297:bound [Spatial Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1533124:Box [Medical Device]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "TBP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "has"

Phrase: "a saddle-like shape with its concave face"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0332485:Concave shape [Spatial Concept]
   767   C0332487:Saddle shape [Spatial Concept]
   744   C0332479:Shape [Spatial Concept]
   744   C0348078:shape [Qualitative Concept]
   744   C0522512:Shape [Spatial Concept]

Phrase: "contacting"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332158:contacting [Functional Concept]
   966 E C0337611:Contact [Population Group]
   966 E C1705415:Contact [Idea or Concept]

Phrase: "the DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "its convex one interacting with the"

Phrase: "other TFIID subunits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "the TBP-associated factors"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C1136066:TATA-Binding Protein Associated Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   900   C0144555:TATA-Binding Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           TATA-Binding Protein
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0243122:binding [Functional Concept]
   804   C0332281:Associated [Qualitative Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   771 E C0750490:Associate [Idea or Concept]
   771   C1521761:Factor [Functional Concept]
   771 E C1706221:Associate [Professional or Occupational Group]
   771   C2827422:Factor [Conceptual Entity]

Phrase: "(TAFs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1336572:TAF [Gene or Genome]

Phrase: ")"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.155: The tertiary structural change caused by polyglutamine expansion in TBP may lead to an aberrant affinity for TAFs, culminating in altered gene expression and cell death. 

Phrase: "The tertiary structural change"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0392747:Change [Functional Concept]
   827   C0443172:change [Quantitative Concept]
   827   C0678594:Structural [Spatial Concept]
   827   C1705241:Change [Quantitative Concept]

Phrase: "caused by polyglutamine expansion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "in TBP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "may"

Phrase: "lead to an aberrant affinity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0443127:Aberrant [Qualitative Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "for TAFs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1336572:TAF [Gene or Genome]

Phrase: "culminating in altered gene expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0017262:Gene Expression [Genetic Function]
   760   C0017337:Gene [Gene or Genome]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0205260:Culminating [Qualitative Concept]
   760   C0392747:Altered [Functional Concept]

Phrase: "and"

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.156: Indeed, human TAFp130 that binds to the polyglutamine domain of the DRPLA protein is lengthdependent (9). 

Phrase: "Indeed,"

Phrase: "human TAFp130"

Phrase: "that"

Phrase: "binds to the polyglutamine domain of the DRPLA protein"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0393578:Pallidoluysian atrophy [Disease or Syndrome]
   751   C0162808:Protein Domain [Spatial Concept]
   751   C1514562:Protein Domain [Amino Acid Sequence]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0333641:Atrophy [Pathologic Function]
   736   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   736   C1145667:Bind [Activity]
   736   C1167622:bind [Molecular Function]
   736   C1880389:Domain [Functional Concept]
   736   C1883221:Domain [Conceptual Entity]
   736   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "lengthdependent"

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.157: Lin et al. 

Phrase: "Lin et al."
Processing 00000000.tx.158: (8) reported that in transgenic mice the expression of several neuronal genes involved in calcium homeostasis and signal transduction are down-regulated very soon after the expression of mutant ataxin-1 protein (8). 

Phrase: "(8"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0025936:Mice, Transgenic [Mammal]
   770   C0003069:Transgenic [Animal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]

Phrase: "the expression of several neuronal genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0017262:Gene Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "involved in calcium homeostasis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0006726:Calcium [Inorganic Chemical]
   770   C0019868:Homeostasis [Biologic Function]
   770   C1314939:Involved [Functional Concept]
   770   C2936886:Calcium [Pharmacologic Substance]

Phrase: "and"

Phrase: "signal transduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037083:Signal Transduction [Cell Function]
   861   C1160185:transduction [Organism Function]
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "are"

Phrase: "down-regulated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0851285:Regulated [Governmental or Regulatory Activity]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "very soon after the expression of mutant ataxin-1 protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1538298:ATAXIN 1 [Gene or Genome]
   760   C1883708:Soon After [Temporal Concept]
   757   C1171362:expression protein [Genetic Function]
   757   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0442824:Very [Qualitative Concept]
   739   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.159: Polyglutamine-expanded huntingtin, but not normal huntingtin, interacts both invivo and in vitro with the transcriptional repressor N-CoR (nuclear receptor corepressor), and N-CoR and at least one of its corepressors, Sin3, are localized ectopically in the cytoplasm of brain sections from HD patients (31). 

Phrase: "Polyglutamine-expanded huntingtin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0252274:Huntingtin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1415504:HUNTINGTIN [Gene or Genome]

Phrase: "but"

Phrase: "not normal huntingtin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0252274:Huntingtin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1415504:HUNTINGTIN [Gene or Genome]

Phrase: "interacts"

Phrase: "both invivo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515655:In Vivo [Spatial Concept]

Phrase: "and"

Phrase: "in vitro with the transcriptional repressor N-CoR (nuclear receptor corepressor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0021135:In Vitro [Intellectual Product]
   756   C1533691:in vitro [Qualitative Concept]
           vitro
   756   C2827718:In Vitro [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "N-CoR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1334870:N-CoR [Gene or Genome]
  1000   C1384567:N-CoR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018787:Cor [Body Part, Organ, or Organ Component]
   861   C0056331:COR [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "and at least one of its corepressors,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205447:One [Quantitative Concept]
   748   C1515981:And [Idea or Concept]
   748   C2717951:Corepressors [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Sin3,"

Phrase: "are"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "ectopically in the cytoplasm of brain sections"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0010834:Cytoplasm [Cell Component]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   714   C0205155:Section [Spatial Concept]
   714   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   714   C1522472:Section [Substance]
   714   C1552923:Section [Quantitative Concept]
   714   C1705191:Section [Physical Object]

Phrase: "from HD patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0020179:Huntington Disease [Disease or Syndrome]
   734   C2919056:Huntington's Disease [Functional Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.160: In contrast, co-localization of transcription factors such as CREB-binding protein (CBP) (10,32), TBP itself (33,34), TAFII130 (9) and Sin3a (31), is reported to be recruited into the NIIs. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "co-localization of transcription factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "such as CREB-binding protein (CBP)"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0256079:CREB-binding protein [Amino Acid, Peptide, or Protein]
  1000   C1337090:CREB-BINDING PROTEIN [Gene or Genome]
  1000   C1530423:CREB-Binding Protein [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0056695:CREB Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1149372:CREB binding [Genetic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "(10,"

Phrase: "32"

Phrase: ")"

Phrase: ","

Phrase: "TBP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "itself"

Phrase: "(33,"

Phrase: "34"

Phrase: ")"

Phrase: ","

Phrase: "TAFII130"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1336567:TAFII130 [Gene or Genome]
  1000   C1336585:TAFII130 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1704907:TAFII130 [Gene or Genome]

Phrase: "(9"

Phrase: ")"

Phrase: "and"

Phrase: "Sin3a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1426185:SIN3A [Gene or Genome]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "recruited into the NIIs."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   814   C1366904:Intranuclear Inclusion Bodies [Cell Component]
           Intranuclear inclusion
   778   C0007637:Inclusion Bodies [Cell Component]
   757   C0230595:Intranuclear body [Cell Component]
   748   C0242821:bodies [Human]
   748   C0521390:Neuronal [Immunologic Factor]
   748   C1512693:Inclusion [Qualitative Concept]
   748   C1995017:Bodies [Cell Component]
   721   C0682679:neuron body [Cell Component]
   714 E C0460148:Body [Anatomical Structure]
   714 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.161: All these findings provide strong evidence that in polyglutamine diseases major transcriptional changes occur in the nucleus. 

Phrase: "All"

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "strong evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that in polyglutamine diseases major transcriptional changes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0012634:Diseases [Disease or Syndrome]
   748   C0040649:Transcriptional [Genetic Function]
   748   C0205164:Major [Qualitative Concept]
   748   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "occur in the nucleus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007610:Nucleus [Cell Component]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.162: Further study of what takes place in the dying neurons nucleus in this disease should provide important information for unraveling the molecular pathogenesis of neuronal cell degeneration as well as for the development of future therapeutic interventions.  

Phrase: "Further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "study of what"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0557651:Study [Manufactured Object]
   790   C2603343:Study [Research Activity]

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "place in the dying neurons nucleus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0442504:Place [Spatial Concept]
   753   C1704765:Place [Functional Concept]
   753   C1882509:Place [Activity]
   753   C3496241:place [Disease or Syndrome]

Phrase: "in this disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "should"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "important information for unraveling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1533716:Information [Idea or Concept]

Phrase: "the molecular pathogenesis of neuronal cell degeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]

Phrase: "as well as for the development of future therapeutic interventions."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   760   C0087111:Therapeutic Interventions [Therapeutic or Preventive Procedure]
   760   C0808232:therapeutic interventions [Therapeutic or Preventive Procedure]
   739   C0016884:Future [Temporal Concept]
   739   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   739   C0205170:Well [Qualitative Concept]
   739   C0243107:development [Physiologic Function]
   739   C0302350:Therapeutic [Functional Concept]
   739   C0678723:Development [Organism Function]
   739   C0886296:interventions [Health Care Activity]
   739   C1273869:Interventions [Health Care Activity]
   739   C1527148:Development [Functional Concept]
   739   C2979881:Interventions [Clinical Attribute]
   739   C3146287:Well [Manufactured Object]
   739   C3542921:Interventions [Classification]
   706 E C1948041:Intervention [Therapeutic or Preventive Procedure]
Processing 00000000.tx.163: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Patients We interviewed families and collected blood samples after obtaining the fully informed consent of the patients and their families. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "We"

Phrase: "interviewed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0021822:Interview [Activity]
   966   C0935630:Interview [Intellectual Product]

Phrase: "families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "and"

Phrase: "collected blood samples after obtaining"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0178913:blood samples [Body Substance]
   745   C0200345:collection sample [Laboratory Procedure]
   734   C1277697:Sample obtained [Finding]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "the fully informed consent of the patients"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   778   C0021430:Informed Consent [Regulation or Law]
   774   C0588446:informed patients [Health Care Activity]
   757 E C1631603:Patient informed [Finding]
   748   C1511481:Consent [Functional Concept]
   748   C1522154:Informed [Qualitative Concept]
   748   C1554192:consent [Idea or Concept]
   714 E C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   714 E C0700287:inform [Health Care Activity]
   714 E C1552002:inform [Idea or Concept]

Phrase: "and"

Phrase: "their families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.164: Western blot analysis of lymphoblasts This procedure is described in detail elsewhere (12,35). 

Phrase: "Western blot analysis of lymphoblasts"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]

Phrase: "This procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1948041:Procedure [Therapeutic or Preventive Procedure]
  1000   C2700391:Procedure [Activity]
  1000   C3274430:PROCEDURE [Health Care Activity]
  1000   C3538935:Procedure [Idea or Concept]
  1000   C3539779:Procedure [Intellectual Product]

Phrase: "is"

Phrase: "described in detail elsewhere"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1522508:Detail [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C1561567:detail [Functional Concept]

Phrase: "(12,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.165: Briefly, lymphoblast cells (5 x 106) were washed in phosphate-buffered saline (PBS) and resuspended in 2 ml of Tris-buffered saline (TBS, 20 mM TrisHCl, 150 mM sodium chloride pH7.5) with 1 mM EDTA and the protease inhibitors (Complete, Boehringer Mannheim, Germany). 

Phrase: "Briefly,"

Phrase: "lymphoblast cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(5 x 106"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "washed in phosphate-buffered saline (PBS)"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1548982:Washed [Idea or Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "resuspended in 2 ml of Tris-buffered saline"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   754   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   744   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0036082:Saline [Substance]
   744   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   744   C0439526:/mL [Quantitative Concept]
   744   C0814229:TRI [Intellectual Product]

Phrase: "(TBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
  1000   C1532188:Tbsp [Quantitative Concept]

Phrase: "20 mM TrisHCl,"

Phrase: "150 mM sodium chloride pH7.5"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   867   C0771135:sodium chloride 5% [Clinical Drug]
   827   C0037494:Sodium Chloride [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   799   C0008203:Chloride, NOS [Inorganic Chemical]
   799   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   799   C0596019:Chloride [Element, Ion, or Isotope]
   799   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: "with 1 mM EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "the protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Complete, Boehringer Mannheim,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.166: The cells were then homogenized in an ultrasonicator and centrifuged at 10 000 g at 4C for 30 min. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "homogenized in an ultrasonicator"

Phrase: "and"

Phrase: "centrifuged at 10 000 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.167: The supernatant was collected, and the protein concentration determined with a BCA protein assay kit (Pierce, Rockford, IL). 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the protein concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427716:Protein concentration [Laboratory Procedure]
  1000   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "determined with a BCA protein assay kit (Pierce,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   744   C0005507:Assay [Laboratory Procedure]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0243073:assay [Qualitative Concept]
   744   C0812225:KIT [Medical Device]
   744   C1150635:KIT [Molecular Function]
   744   C1332420:bca [Gene or Genome]
   744   C1510438:Assay [Laboratory Procedure]
   744   C1705212:Kit [Medical Device]
   744   C1705213:KIT [Medical Device]
   744   C3273202:Kit [Manufactured Object]

Phrase: "Rockford,"

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")."
Processing 00000000.tx.168: Samples were stored at 80 C until they were used. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "stored at 80 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1698986:Store [Functional Concept]

Phrase: "until"

Phrase: "they"

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.169: Protein samples (50 g/lane) were separated by SDSPAGE in a 0.1% SDS/520% gradient polyacrylamide gel then transferred to Immobilon membranes (Millipore, MA). 

Phrase: "Protein samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "(50 g/lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "separated by SDSPAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "in a 0.1% SDS/520% gradient polyacrylamide gel then"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   793   C0017243:Gel [Biomedical or Dental Material]
   793   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   793   C1382104:Gel [Substance]

Phrase: "transferred to Immobilon membranes"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0025255:Membranes [Tissue]
   770   C0063412:Immobilon [Organic Chemical,Pharmacologic Substance]
   770   C0348011:transferred [Functional Concept]
   737 E C0040671:Transfer [Mental Process]
   737 E C0596901:Membrane [Cell Component]
   737 E C1705822:Transfer [Activity]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "(Millipore,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.170: The membranes were blocked with 1% bovine serum albumin and 4% dry milk in TBST buffer (TBS with 0.05% Tween 20) for 1 h at room temperature, after which they were incubated overnight at 4C in 3% dry milk/TBST with the 1C2 Ab (1:2000; 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "blocked with 1% bovine serum albumin"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   833   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   790   C0728877:serum albumin [Laboratory or Test Result]
   783 E C0523465:Albumin - serum [Laboratory Procedure]
   753   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0007452:Bovine [Mammal]
   753   C0028778:Blocked [Pathologic Function]
   753   C0229671:Serum [Body Substance]
   753   C0332206:Blocked [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "4% dry milk in TBST buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0026131:Milk [Body Substance]
   753   C0349374:Milk [Food]
   753   C0444318:Milk [Substance]
   753   C2825079:Milk [Food]

Phrase: "(TBS with 0.05% Tween 20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   753   C1532188:Tbsp [Quantitative Concept]

Phrase: ")"

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "after"

Phrase: "which they"

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439583:Overnight [Temporal Concept]
   790   C0450376:4c [Intellectual Product]

Phrase: "in 3% dry milk/TBST"

Phrase: "with the 1C2 Ab (1"

Phrase: ":"

Phrase: "2000"

Phrase: ";"
Processing 00000000.tx.171: Chemicon, Temecula, CA) and given three 10 min washes in TBST. 

Phrase: "Chemicon,"

Phrase: "Temecula,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555271:Temecula [Population Group]

Phrase: "CA)"

Phrase: "and"

Phrase: "given three 10 min washes in TBST."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0441648:Wash [Activity]
Processing 00000000.tx.172: The filters then were incubated in 3% dry milk/TBST with HRP-conjugated secondary anti-mouse Ig Ab (1:5000). 

Phrase: "The filters then"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0180860:Filters [Manufactured Object]
   827 E C0581406:Filter [Medical Device]
   827 E C1522664:Filter [Intellectual Product]
   827 E C1704449:Filter [Conceptual Entity]
   827 E C1704684:Filter [Medical Device]
   827 E C1875155:FILTER [Medical Device]

Phrase: "were"

Phrase: "incubated in 3% dry milk/TBST"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0011682:Dry [Natural Phenomenon or Process]
   753   C0026131:Milk [Body Substance]
   753   C0205222:Dry [Qualitative Concept]
   753   C0349374:Milk [Food]
   753   C0444318:Milk [Substance]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1512080:Dry [Qualitative Concept]
   753   C2825079:Milk [Food]

Phrase: "with HRP-conjugated secondary anti-mouse Ig Ab (1"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   793   C0019941:HRP [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   793   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   793   C0025914:Mouse [Mammal]
   793   C0025929:mouse [Mammal]
   793   C0026809:Mouse [Mammal]
   793   C0027627:secondary [Neoplastic Process]
   793   C0175668:Secondary [Temporal Concept]
   793   C0205436:Secondary [Quantitative Concept]
   793   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   793   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   793   C0522529:Conjugated [Spatial Concept]
   793   C3541296:IG [Idea or Concept]
   721 E C1160466:conjugation [Cell Function]

Phrase: ":"

Phrase: "5000"

Phrase: ")."
Processing 00000000.tx.173: Finally, the reaction was made visible with an enhanced chemiluminescence (ECL) western blotting kit (Amersham Pharmacia Biotech, UK) according to the manufacturers protocol. 

Phrase: "Finally,"

Phrase: "the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "visible with an enhanced chemiluminescence (ECL) western blotting kit (Amersham Pharmacia Biotech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0205379:Visible [Qualitative Concept]

Phrase: "UK"

Phrase: ")"

Phrase: "according to the manufacturers protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.174: Mouse monoclonal anti-TBP antibody (1TBP18; QED Bioscience, CA) at 1:2000 dilution was used for the TBP immunoblotting. 

Phrase: "Mouse monoclonal anti-TBP antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   900   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   877   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   710   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1TBP18"

Phrase: "; QED Bioscience,"

Phrase: "CA) at 1"

Phrase: ":"

Phrase: "2000 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: "was"

Phrase: "used for the TBP immunoblotting."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   814   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774 E C0033618:Protein Binding [Molecular Function]
   748   C0020985:Immunoblotting [Laboratory Procedure]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1273517:used [Finding]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.175: PCR and GeneScan analysis of the TBP gene The PCR of the TBP gene was done with the forward primer TBP-F, 5'-CCTTATGGCACTGGACTGAC-3', and reverse primer TBP-R, 5'-GTTCCCTGTGTTGCCTGCTG-3'. 

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "GeneScan analysis of the TBP gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1514534:Protein Analysis [Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "The PCR of the TBP gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "done with the forward primer TBP-F,"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   790   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1953382:Forward primer [Cell]
   764   C2945724:protein f [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762 E C0033618:Protein Binding [Molecular Function]
   742   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0243122:binding [Functional Concept]
   742   C0439133:(f) [Intellectual Product]
   742   C0439780:Forward [Spatial Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1272695:Done [Qualitative Concept]
   742   C1553038:[f] [Quantitative Concept]
   742   C2746065:Done [Temporal Concept]

Phrase: "5'-CCTTATGGCACTGGACTGAC-3',"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "reverse primer TBP-R,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0168981:protein r [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0205090:R- [Spatial Concept]
   799   C0684010:R. [Professional or Occupational Group]
   799   C2603358:R' [Clinical Attribute]

Phrase: "5'-GTTCCCTGTGTTGCCTGCTG-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.176: The patients genomic DNA was amplified in a 25 l reaction mixture containing DNA template (60150 ng), dNTP (200 M each), 10 pmol of each primer, 2.5 l of 10x PCR buffer and AmpliTaq Gold polymerase (5 U; Perkin Elmer, Foster City, CA). 

Phrase: "The patients genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017428:Genomic [Gene or Genome]
   827   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "amplified in a 25 l reaction mixture containing DNA template"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0678713:DNA template [Genetic Function]
   739   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0332256:Containing [Functional Concept]
   739   C0439962:Mixture [Substance]
   739   C0443286:Reaction [Functional Concept]
   739   C0728990:TEMPLATE [Medical Device]
   739   C1114821:Reaction [Clinical Attribute]
   739   C1514575:Template [Conceptual Entity]
   739   C1705542:Template [Idea or Concept]
   739   C2700400:Containing [Activity]

Phrase: "(60150 ng"

Phrase: ")"

Phrase: ","

Phrase: "dNTP (200 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "each"

Phrase: ")"

Phrase: ","

Phrase: "10 pmol of each primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439192:pmol [Quantitative Concept]

Phrase: "2.5 l of 10x PCR buffer"

Phrase: "and"

Phrase: "AmpliTaq Gold polymerase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(5 U"

Phrase: "; Perkin Elmer,"

Phrase: "Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA)."
Processing 00000000.tx.177: Optimal PCR conditions were initial denaturation at 95C for 12 min, followed by 40 cycles of 20 s at 95C, 1 min at 60C, 1 min at 72C, and final extension at 72C for 10 min. 

Phrase: "Optimal PCR conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "initial denaturation at 95C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0301642:Denaturation [Molecular Function]

Phrase: "for 12 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "followed by 40 cycles of 20 s"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0439509:/40 [Temporal Concept]
   714   C1511572:Cycle [Temporal Concept]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "at 95C,"

Phrase: "1 min at 60C,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1301862:Min 1 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "1 min at 72C,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1301862:Min 1 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "final extension at 72C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0231448:Extension [Functional Concept]
   770   C1880641:Extension [Conceptual Entity]

Phrase: "for 10 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.178: All the PCR reactions were done in a thermal cycler (iCycler; Bio-Rad, Hercules, CA). 

Phrase: "All"

Phrase: "the PCR reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "done in a thermal cycler"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1611676:Thermal Cycler [Medical Device]
   760   C1272695:Done [Qualitative Concept]
   760   C2746065:Done [Temporal Concept]

Phrase: "(iCycler"

Phrase: "; Bio-Rad,"

Phrase: "Hercules,"

Phrase: "CA)."
Processing 00000000.tx.179: PCR products were separated by electrophoresis through 3.5% agarose and made visible by CYBER Green I (Molecular Probes, Eugene, OR) staining. 

Phrase: "PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "separated by electrophoresis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "through 3.5% agarose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036681:Agarose [Carbohydrate]
   734   C0442758:3 5 [Quantitative Concept]

Phrase: "and"

Phrase: "made visible by CYBER Green I (Molecular Probes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205379:Visible [Qualitative Concept]

Phrase: "Eugene,"

Phrase: "OR) staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]
Processing 00000000.tx.180: For the GeneScan analysis, forward primer TBP-F was replaced by FAM-labeled primers (TBP-FAM). 

Phrase: "For the GeneScan analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "forward primer TBP-F"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C2945724:protein f [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   799   C0439133:(f) [Intellectual Product]
   799   C1553038:[f] [Quantitative Concept]

Phrase: "was"

Phrase: "replaced by FAM-labeled primers"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C1299987:Replaced by [Functional Concept]
           replaced
   760   C0559956:Replaced [Functional Concept]
   760   C1708632:Labeled [Qualitative Concept]
   760   C3541878:FAM [Gene or Genome]
   726 E C0181496:Label [Manufactured Object]
   726   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   726 E C1554078:Replace [Idea or Concept]
   726 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(TBP-FAM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C3541878:FAM [Gene or Genome]
   756   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.181: The GS500 TAMRA-labeled size standard (Perkin Elmer) and PCR products were run simultaneously in the same lanes. 

Phrase: "The GS500 TAMRA-labeled size standard"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1442989:Standard [Qualitative Concept]
   804   C2828392:Standard [Intellectual Product]

Phrase: "(Perkin Elmer"

Phrase: ")"

Phrase: "and"

Phrase: "PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "run"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035953:run [Daily or Recreational Activity]
  1000   C0600140:run [Finding]
  1000   C1704688:Run [Functional Concept]
  1000   C2346414:Run [Finding]

Phrase: "simultaneously in the same lanes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0445247:Same [Qualitative Concept]
   760   C0521115:simultaneously [Temporal Concept]
   726   C1708639:Lane [Spatial Concept]
Processing 00000000.tx.182: The CAG repeat size was determined with an ABI 377XL DNA sequencer and GeneScan version 3.1 software. 

Phrase: "The CAG repeat size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0456389:size [Spatial Concept]

Phrase: "was"

Phrase: "determined with an ABI 377XL DNA sequencer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1328319:ABI [Clinical Attribute]

Phrase: "and"

Phrase: "GeneScan version 3.1 software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.183: Direct sequencing of CAG/CAA polymorphism in the TBP gene Amplified DNA fragments bearing the TBP gene (nucleotides 338563; 

Phrase: "Direct sequencing of CAG/CAA polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1553778:Sequencing [Intellectual Product]
   753   C1561491:Sequencing [Functional Concept]

Phrase: "in the TBP gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Amplified"

Phrase: "DNA fragments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684192:DNA fragments [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the TBP gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(nucleotides 338563"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.184: NM_003194, gi: 4507378) were subcloned into pGEM-T Easy vector (Promega, Madison, WI). 

Phrase: "NM_003194,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "gi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539617:GI [Idea or Concept]

Phrase: ":"

Phrase: "4507378"

Phrase: ")"

Phrase: "were"

Phrase: "subcloned into pGEM-T Easy vector"

Phrase: "(Promega,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: "Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")."
Processing 00000000.tx.185: DNA sequences of the polymorphic site in the TBP gene were verified in 10 individual clones from each genomic DNA template. 

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "sequences of the polymorphic site"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   797   C2945843:Site of [Qualitative Concept]
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C1519249:Sequence [Functional Concept]
   760   C1882417:Polymorphic [Qualitative Concept]
   760   C2825164:Site [Spatial Concept]

Phrase: "in the TBP gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "verified in 10 individual clones"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0009013:Clones [Cell]
   760   C0027361:Individual [Population Group]
   760   C0237401:Individual [Human]
   760   C1711411:Verified [Functional Concept]
   726 E C1522642:Clone [Tissue]

Phrase: "from each genomic DNA template."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0678713:DNA template [Genetic Function]
   827   C0728990:TEMPLATE [Medical Device]
   827   C1514575:Template [Conceptual Entity]
   827   C1705542:Template [Idea or Concept]
   734   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.186: Homozygotic or heterozygotic CAG alleles of the TBP gene were also authenticated on the basis of the CAG/CAA numbers obtained from the GeneScan analysis. 

Phrase: "Homozygotic"

Phrase: "or"

Phrase: "heterozygotic CAG alleles of the TBP gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0002085:Alleles [Gene or Genome]

Phrase: "were"

Phrase: "also"

Phrase: "authenticated on the basis of the CAG/CAA numbers"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0237753:*Number [Quantitative Concept]
   742   C0449788:Number [Quantitative Concept]
   742   C1527178:Basis [Functional Concept]
   742   C1548383:authenticated [Idea or Concept]
   742   C1874451:Basis [Pharmacologic Substance]

Phrase: "obtained from the GeneScan analysis."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1301820:Obtained [Functional Concept]
   760   C1524024:analysis [Functional Concept]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.187: Immunocytochemical analysis of postmortem brain tissue We obtained postmortem brain tissue (pedigree C, III-5) from the brain bank (NH No. A-157) at the Tokyo Metropolitan Institute for Neuroscience. 

Phrase: "Immunocytochemical analysis of postmortem brain tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "We"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "postmortem brain tissue"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C0444184:Postmortem tissue [Tissue]
   901   C0440746:Brain tissue [Tissue]
   901   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0040300:Tissue [Tissue]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1547928:Tissue [Intellectual Product]

Phrase: "(pedigree C,"

Phrase: "III-5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "from the brain bank"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442598:Bank [Manufactured Object]
   861   C0872261:Bank [Manufactured Object]

Phrase: "(NH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0268059:NH [Disease or Syndrome]

Phrase: "No. A-157"

Phrase: ")"

Phrase: "at the Tokyo Metropolitan Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021622:institute [Organization]
   827   C1272753:Institute [Idea or Concept]

Phrase: "for Neuroscience."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]
Processing 00000000.tx.188: Formalin-fixed, paraffin-embedded sections, 4 mm thick, were prepared from the caudate nucleus, putamen and frontal cortex of the patient and the control subjects. 

Phrase: "Formalin-fixed, paraffin-embedded sections,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   771   C0205155:Section [Spatial Concept]
   771   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   771   C1522472:Section [Substance]
   771   C1552923:Section [Quantitative Concept]
   771   C1705191:Section [Physical Object]

Phrase: "4 mm"

Phrase: "thick,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1280412:Thick [Qualitative Concept]

Phrase: "were"

Phrase: "prepared from the caudate nucleus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0007461:Caudate Nucleus [Body Part, Organ, or Organ Component]
   806   C1269580:Caudate nucleus [Body Part, Organ, or Organ Component]
   760   C0007610:Nucleus [Cell Component]
   726   C1521827:Prepare [Functional Concept]

Phrase: "putamen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034169:Putamen [Body Part, Organ, or Organ Component]
  1000   C1281335:Putamen [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "frontal cortex of the patient"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   760   C0007776:Cortex [Body Part, Organ, or Organ Component]
   760   C0205123:Frontal [Spatial Concept]
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "the control subjects."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.189: Two pre-treatment protocols were used. 

Phrase: "Two pre-treatment protocols"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040808:Treatment Protocols [Therapeutic or Preventive Procedure]
   812   C0442711:Protocols [Intellectual Product]
   779 E C1507394:Protocol [Intellectual Product]
   779 E C1522729:Protocol [Intellectual Product]
   779 E C2348563:Protocol [Intellectual Product]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.190: Sections were autoclaved and treated with 99% formic acid for 5 min at room temperature or microwaved in 10 mM citrate buffer (pH6.0), then treated with 1% periodic acid for 15 min, after which they were immunostained by the ABC method (Vector, Burlingame, CA) with mouse monoclonal 1C2 (1:100016 000, Chemicon), rabbit polyclonal (sc204, 1:20 000, Santa Cruz; 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "autoclaved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179177:Autoclave [Medical Device]

Phrase: "and"

Phrase: "treated with 99% formic acid"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   806   C0885348:formic acid [Organic Chemical]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "or"

Phrase: "microwaved in 10 mM citrate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C3256468:citrate buffer [Pharmacologic Substance]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0008857:Citrate [Organic Chemical]
   753   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   719   C0026051:Microwave [Natural Phenomenon or Process]

Phrase: "(pH6.0"

Phrase: ")"

Phrase: ","

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "treated with 1% periodic acid"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0031068:Periodic Acid [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0332182:Periodic [Temporal Concept]
   760   C1522326:Treated [Functional Concept]
   760   C1706381:PERIODIC [Intellectual Product]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "for 15 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "after"

Phrase: "which they"

Phrase: "were"

Phrase: "immunostained by the ABC method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]

Phrase: "(Vector,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "Burlingame,"

Phrase: "CA) with mouse monoclonal 1C2"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100016 000,"

Phrase: "Chemicon"

Phrase: ")"

Phrase: ","

Phrase: "rabbit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: "polyclonal"

Phrase: "(sc204,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "20 000,"

Phrase: "Santa Cruz"

Phrase: ";"
Processing 00000000.tx.191: Santa Cruz, CA), mouse monoclonal (1TBP18, 1:20000, QED Bioscience; 

Phrase: "Santa Cruz,"

Phrase: "CA),"

Phrase: "mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "monoclonal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0746619:monoclonal [Finding]

Phrase: "(1TBP18,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "20000,"

Phrase: "QED Bioscience"

Phrase: ";"
Processing 00000000.tx.192: San Diego, CA), anti-TBP antibody or rabbit polyclonal antibody against ubiquitin (1:1000; 

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA),"

Phrase: "anti-TBP antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "rabbit polyclonal antibody against ubiquitin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   797   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ";"
Processing 00000000.tx.193: Dakopatts, Carpinteria, CA). 

Phrase: "Dakopatts,"

Phrase: "Carpinteria,"

Phrase: "CA)."
Processing 00000000.tx.194: Diaminobenzidine was used as the chromogen. 

Phrase: "Diaminobenzidine"

Phrase: "was"

Phrase: "used as the chromogen."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0052799:Chromogen [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.195: Double immunofluorescence analysis was performed by incubating de-paraffinized sections with a mixture of 1C2 monoclonal antibody (1:1000) and anti-ubiquitin (1:500) or anti-TBP (1:250) rabbit polyclonal antibody. 

Phrase: "Double immunofluorescence analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed by incubating de-paraffinized sections"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   790   C1550369:Performed By [Qualitative Concept]
   753   C0011198:DE [Geographic Area]
   753   C0017480:DE [Geographic Area]
   753   C0884358:Performed [Functional Concept]
   753   C1439852:incubating [Laboratory Procedure]
   753   C3541240:DE [Idea or Concept]
   719   C0205155:Section [Spatial Concept]
   719   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   719   C1522472:Section [Substance]
   719   C1552923:Section [Quantitative Concept]
   719   C1705191:Section [Physical Object]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "with a mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:Mixture [Substance]

Phrase: "of 1C2 monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ")"

Phrase: "and"

Phrase: "anti-ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ")"

Phrase: "or"

Phrase: "anti-TBP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "250"

Phrase: ")"

Phrase: "rabbit polyclonal antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.196: Anti-mouse IgG coupled with Rhodamine red (1:200, Jackson ImmunoRes, West Grove, PA) was used to make the 1C2 epitope visible. 

Phrase: "Anti-mouse IgG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "coupled with Rhodamine red (1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0332575:Red [Finding]
   760   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1260956:Red [Qualitative Concept]
   760   C1948027:Coupled [Functional Concept]
   726 E C0010222:couple [Family Group]

Phrase: ":"

Phrase: "200,"

Phrase: "Jackson ImmunoRes,"

Phrase: "West Grove,"

Phrase: "PA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "the 1C2 epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: "visible."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205379:Visible [Qualitative Concept]
Processing 00000000.tx.197: Anti-rabbit Ig G coupled with horseradish peroxidase (1:1000, Pierce, Rockford, IL) reacted with biotinylated tyramide which enabled the other epitope to be made visible with FITC conjugated with streptavidin (1:200, Vector). 

Phrase: "Anti-rabbit Ig G"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0439267:g% [Quantitative Concept]
   812   C3541296:IG [Idea or Concept]

Phrase: "coupled with horseradish peroxidase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0330510:Horseradish [Food]
   770   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   770   C1110641:Horseradish [Plant]
   770   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   770   C1948027:Coupled [Functional Concept]
   737 E C0010222:couple [Family Group]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000,"

Phrase: "Pierce,"

Phrase: "Rockford,"

Phrase: "IL)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: "reacted with biotinylated tyramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0673361:biotinylated tyramide [Organic Chemical]

Phrase: "which"

Phrase: "enabled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0562342:Enabled [Mental Process]
   966 E C1171285:enable [Mental Process]

Phrase: "the other epitope to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: "be"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "visible with FITC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205379:Visible [Qualitative Concept]

Phrase: "conjugated with streptavidin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0075278:Streptavidin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]
   790   C0522529:Conjugated [Spatial Concept]
   756 E C0301869:Conjugate [Immunologic Factor]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200,"

Phrase: "Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.198: After being mounted with Vectashield (Vector), the sections were observed under a fluorescent microscope equipped with a laser confocal system (TCS-SP, Leica, Heidelberg, Germany).  

Phrase: "After"

Phrase: "being"

Phrase: "mounted with Vectashield"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0449878:mounted [Finding]
   756 E C0181909:Mount [Medical Device]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "observed under a fluorescent microscope"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0181839:Microscope [Medical Device]
   760   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1441672:Observed [Functional Concept]
   760   C1706379:Microscope [Medical Device]

Phrase: "equipped with a laser confocal system"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0023089:Laser [Manufactured Object]
   753   C0449913:System [Functional Concept]
   753   C0458142:Laser [Phenomenon or Process]
   753   C1023865:Laser [Plant]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   753   C1706315:Laser [Medical Device]

Phrase: "(TCS-SP,"

Phrase: "Leica,"

Phrase: "Heidelberg,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.199: ACKNOWLEDGEMENTS  We are grateful to Dr N. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Dr N."
Processing 00000000.tx.200: Arai (Department of Clinical Neuropathology, Tokyo Metropolitan Institute for Neuroscience) who provided the autopsied brain sample for DNA analysis. 

Phrase: "Arai"

Phrase: "(Department of Clinical Neuropathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0587493:Neuropathology department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "Tokyo Metropolitan Institute for Neuroscience"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: ")"

Phrase: "who"

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "the autopsied brain sample for DNA analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1303103:Sample analysis [Laboratory Procedure]
   748   C0370003:Sample [Substance]
   748   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.201: We also thank N. 

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.202: Koikeda, N. 

Phrase: "Koikeda,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.203: Tsuji, M. 

Phrase: "Tsuji,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.204: Arai and K. 

Phrase: "Arai"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.205: Matsuba for their technical assistance. 

Phrase: "Matsuba for their technical assistance."
Processing 00000000.tx.206: This work was supported in part by a grant-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant no. 112210051).  

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by a grant-in-aid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0018173:Grant [Quantitative Concept]
   827   C0018896:Aid [Social Behavior]
   827   C0449435:Aid [Manufactured Object]
   827   C1548284:Grant [Idea or Concept]
   827   C3540469:AID [Gene or Genome]

Phrase: "for Scientific Research"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0683933:scientific research [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0036397:Scientific [Occupation or Discipline]
   861   C0242481:Research [Research Activity]

Phrase: "on Priority Areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "from the Ministry"

Phrase: "of Education,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0013621:Education [Educational Activity]
  1000   C0013622:education [Classification]
  1000   C0013658:Education, NOS [Finding]
  1000   C0039401:Education [Educational Activity]
   928 E C1555905:Educational [Intellectual Product]

Phrase: "Culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "Sports,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038039:Sports [Daily or Recreational Activity]
  1000   C1552306:Sports [Professional or Occupational Group]

Phrase: "Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "and"

Phrase: "Technology of Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0039421:Technology [Occupation or Discipline]

Phrase: "(Grant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018173:Grant [Quantitative Concept]
  1000   C1548284:Grant [Idea or Concept]

Phrase: "no. 112210051"

Phrase: ")."
Processing 00000000.tx.207: FOOTNOTES  + To whom correspondence should be addressed. 

Phrase: "FOOTNOTES  +"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.208: Tel: +81 3 3815 5411; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+81 3 3815 5411"

Phrase: ";"
Processing 00000000.tx.209: Fax: +81 3 5805 5845; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+81 3 5805 5845"

Phrase: ";"
Processing 00000000.tx.210: Email: koichiro-tky@umin.ac.jp  REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  1 Durr, A., Chneiweiss, H., Khati, C., Stevanin, G., Cancel, G., Feingold, J., Agid, Y. and Brice, A. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "koichiro-tky@umin.ac.jp"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1 Durr,"

Phrase: "A.,"

Phrase: "Chneiweiss,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Khati,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Stevanin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Cancel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205544:Cancel [Qualitative Concept]

Phrase: ","

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Feingold,"

Phrase: "J.,"

Phrase: "Agid,"

Phrase: "Y."

Phrase: "and"

Phrase: "Brice,"

Phrase: "A."
Processing 00000000.tx.211: (1993) Phenotypic variability in autosomal dominant cerebellar ataxia type I is unrelated to genetic heterogeneity. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Phenotypic variability in autosomal dominant cerebellar ataxia type I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1853719:Phenotypic variability [Finding]
   742   C2827666:Variability [Conceptual Entity]

Phrase: "is"

Phrase: "unrelated to genetic heterogeneity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0445356:Unrelated [Finding]
   770   C1704623:Unrelated [Qualitative Concept]
Processing 00000000.tx.212: Brain, 116, 14971508.[Abstract] 2 Harding, A.E. 

Phrase: "Brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "116,"

Phrase: "14971508."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 2 Harding,"

Phrase: "A.E."
Processing 00000000.tx.213: (1993) Clinical features and classification of inherited ataxias. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Clinical features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "classification of inherited ataxias."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0008902:Classification [Classification]
   770   C0008903:classification [Functional Concept]
   770   C0678229:classification [Occupational Activity]
Processing 00000000.tx.214: Adv. 

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.215: Neurol., 61, 114.[Medline] 3 Schols, L., Amoiridis, G., Buttner, T., Przuntek, H., Epplen, J.T. and Riess, O. 

Phrase: "Neurol.,"

Phrase: "61,"

Phrase: "114."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 3 Schols,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Amoiridis,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Buttner,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Przuntek,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Epplen,"

Phrase: "J.T."

Phrase: "and"

Phrase: "Riess,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.216: (1997) Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes? 

Phrase: "(1997"

Phrase: ")"

Phrase: "Autosomal dominant cerebellar ataxia"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0007758:Cerebellar Ataxia [Sign or Symptom]
   861   C0443147:Autosomal dominant [Intellectual Product]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   812   C0596142:autosomal [Cell Component]
   812   C1527180:Dominant [Functional Concept]
   812   C1707522:Cerebellar [Tissue]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: ":"

Phrase: "phenotypic differences in genetically defined subtypes?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.217: Ann. 

Phrase: "Ann."
Processing 00000000.tx.218: Neurol., 42, 924932.[ISI][Medline] 4 Perutz, M.F. 

Phrase: "Neurol.,"

Phrase: "42,"

Phrase: "924932."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 4 Perutz,"

Phrase: "M."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.219: (1999) Glutamine repeats and neurodegenerative diseases: molecular aspects. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Glutamine repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205341:repeats [Functional Concept]
   861   C1705914:Repeats [Conceptual Entity]
   827 E C1547730:Repeat [Temporal Concept]

Phrase: "and"

Phrase: "neurodegenerative diseases"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "molecular aspects."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1547011:Aspect [Quantitative Concept]
   827   C1879746:Aspect [Qualitative Concept]
Processing 00000000.tx.220: Trends Biochem. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem."
Processing 00000000.tx.221: Sci., 24, 5863.[ISI][Medline] 5 Cha, J.H. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "24,"

Phrase: "5863."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 5 Cha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420648:CHA [Gene or Genome]

Phrase: "J.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.222: (2000) Transcriptional dysregulation in Huntingtons disease. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Transcriptional dysregulation in Huntingtons disease."
Processing 00000000.tx.223: Trends Neurosci., 23, 387392.[ISI][Medline] 6 Wood, J.D., Nucifora, F.C.,Jr., Duan, K., Zhang, C., Wang, J., Kim, Y., Schilling, G., Sacchi, N., Liu, J.M. and Ross, C.A. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci.,"

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "387392."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 6 Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Nucifora,"

Phrase: "F.C.,Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "Duan,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Zhang,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Wang,"

Phrase: "J.,"

Phrase: "Kim,"

Phrase: "Y.,"

Phrase: "Schilling,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Sacchi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Liu,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C."

Phrase: "A."
Processing 00000000.tx.224: (2000) Atrophin-1, the dentato-rubral and pallido-luysian atrophy gene product, interacts with ETO/MTG8 in the nuclear matrix and represses transcription. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Atrophin-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0380757:atrophin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1540211:ATROPHIN 1 [Gene or Genome]

Phrase: "the dentato-rubral"

Phrase: "and"

Phrase: "pallido-luysian atrophy gene product,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0017337:Gene [Gene or Genome]
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]

Phrase: "interacts with ETO/MTG8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1539715:MTG8 [Gene or Genome]
   770   C1706326:MTG8 [Gene or Genome]

Phrase: "in the nuclear matrix"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028581:Nuclear Matrix [Cell Component]
   861   C0521447:Nuclear [Spatial Concept]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "represses"

Phrase: "transcription."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]
Processing 00000000.tx.225: J. 

Phrase: "J."
Processing 00000000.tx.226: Cell Biol., 150, 939948.[Abstract/Free FullText] 7 Fernandez-Funez, P., Nino-Rosales, M.L., de Gouyon, B., She, W.C., Luchak, J.M., Martinez, P., Turiegano, E., Benito, J., Capovilla, M., Skinner, P.J. et al. 

Phrase: "Cell Biol.,"

Phrase: "150,"

Phrase: "939948."

Phrase: "[Abstract/Free FullText"

Phrase: "] 7 Fernandez-Funez,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Nino-Rosales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0524901:Rosales [Plant]

Phrase: "M.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "de Gouyon,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "She,"

Phrase: "W.C., Luchak,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Martinez,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Turiegano,"

Phrase: "E.,"

Phrase: "Benito,"

Phrase: "J.,"

Phrase: "Capovilla,"

Phrase: "M."

Phrase: ","

Phrase: "Skinner,"

Phrase: "P.J. et al."
Processing 00000000.tx.227: (2000) Identification of genes that modify ataxin-1-induced neurodegeneration. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Identification of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "that"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "ataxin-1-induced neurodegeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.228: Nature, 408, 101106.[ISI][Medline] 8 Lin, X., Antalffy, B., Kang, D., Orr, H.T. and Zoghbi, H.Y. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "408,"

Phrase: "101106."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 8 Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0861352:LIN [Neoplastic Process]

Phrase: "X.,"

Phrase: "Antalffy,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kang,"

Phrase: "D."

Phrase: ","

Phrase: "Orr,"

Phrase: "H.T."

Phrase: "and"

Phrase: "Zoghbi,"

Phrase: "H.Y."
Processing 00000000.tx.229: (2000) Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1 [see comments]. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Polyglutamine expansion"

Phrase: "down-regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "specific neuronal genes before pathologic changes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017337:Genes [Gene or Genome]

Phrase: "in SCA1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:SCA-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0752120:SCA1 [Disease or Syndrome]

Phrase: "["

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "comments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0282411:Comments [Intellectual Product]
  1000   C0947611:comments [Intellectual Product]
  1000   C1705247:Comments [Conceptual Entity]

Phrase: "]."
Processing 00000000.tx.230: Nat. 

Phrase: "Nat."
Processing 00000000.tx.231: Neurosci., 3, 157163.[ISI][Medline] 9 Shimohata, T., Nakajima, T., Yamada, M., Uchida, C., Onodera, O., Naruse, S., Kimura, T., Koide, R., Nozaki, K., Sano, Y. et al. 

Phrase: "Neurosci.,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "157163."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 9 Shimohata,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nakajima,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yamada,"

Phrase: "M."

Phrase: ","

Phrase: "Uchida,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Onodera,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Naruse,"

Phrase: "S."

Phrase: ","

Phrase: "Kimura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Koide,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Nozaki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sano,"

Phrase: "Y. et al."
Processing 00000000.tx.232: (2000) Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Expanded polyglutamine stretches"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0270814:Stretches [Disease or Syndrome]
   793 E C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "interact with TAFII130,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1336567:TAFII130 [Gene or Genome]
   790   C1336585:TAFII130 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1704907:TAFII130 [Gene or Genome]

Phrase: "interfering with CREB-dependent transcription."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0040649:Transcription [Genetic Function]
   760   C0521102:interfering [Qualitative Concept]
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]
Processing 00000000.tx.233: Nat. 

Phrase: "Nat."
Processing 00000000.tx.234: Genet., 26, 2936.[ISI][Medline] 10 Nucifora, F.C.,Jr., Sasaki, M., Peters, M.F., Huang, H., Cooper, J.K., Yamada, M., Takahashi, H., Tsuji, S., Troncoso, J., Dawson, V.L. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "26,"

Phrase: "2936."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 10 Nucifora,"

Phrase: "F.C.,Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "Sasaki,"

Phrase: "M."

Phrase: ","

Phrase: "Peters,"

Phrase: "M."

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Huang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "J.K.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Yamada,"

Phrase: "M."

Phrase: ","

Phrase: "Takahashi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tsuji,"

Phrase: "S."

Phrase: ","

Phrase: "Troncoso,"

Phrase: "J.,"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L. et al."
Processing 00000000.tx.235: (2001) Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Interference by huntingtin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0521102:Interference [Qualitative Concept]

Phrase: "and"

Phrase: "atrophin-1 with cbp-mediated transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0380757:atrophin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1540211:ATROPHIN 1 [Gene or Genome]

Phrase: "leading to cellular toxicity."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   770   C0007634:Cellular [Cell]
   770   C0040539:toxicity [Qualitative Concept]
   770   C0178539:Cellular [Functional Concept]
   770   C0332152:Leading [Temporal Concept]
   770   C0600688:Toxicity [Injury or Poisoning]
   770   C1522538:Leading [Functional Concept]
   756   C0023176:lead poison [Injury or Poisoning]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.236: Science, 291, 24232428.[Abstract/Free FullText] 11 Trottier, Y., Lutz, Y., Stevanin, G., Imbert, G., Devys, D., Cancel, G., Saudou, F., Weber, C., David, G., Tora, L. et al. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "291,"

Phrase: "24232428."

Phrase: "[Abstract/Free FullText"

Phrase: "] 11 Trottier,"

Phrase: "Y.,"

Phrase: "Lutz,"

Phrase: "Y.,"

Phrase: "Stevanin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Imbert,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Devys,"

Phrase: "D."

Phrase: ","

Phrase: "Cancel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205544:Cancel [Qualitative Concept]

Phrase: ","

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Saudou,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Weber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582525:weber [Quantitative Concept]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "David,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tora,"

Phrase: "L. et al."
Processing 00000000.tx.237: (1995) Polyglutamine expansion as a pathological epitope in Huntingtons disease and four dominant cerebellar ataxias. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Polyglutamine expansion as a pathological epitope"

Phrase: "in Huntingtons disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0020179:Huntington Disease [Disease or Syndrome]
  1000   C2919056:Huntington's Disease [Functional Concept]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "four dominant cerebellar ataxias."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0007758:Cerebellar Ataxias [Sign or Symptom]
   812   C0004134:Ataxias [Sign or Symptom]
   729 E C0234366:Ataxic [Sign or Symptom]
Processing 00000000.tx.238: Nature, 378, 403406.[ISI][Medline] 12 Stevanin, G., Trottier, Y., Cancel, G., Durr, A., David, G., Didierjean, O., Burk, K., Imbert, G., Saudou, F., Abada-Bendib, M. et al. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "378,"

Phrase: "403406."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 12 Stevanin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Trottier,"

Phrase: "Y.,"

Phrase: "Cancel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205544:Cancel [Qualitative Concept]

Phrase: ","

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Durr,"

Phrase: "A.,"

Phrase: "David,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Didierjean,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Burk,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Imbert,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Saudou,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Abada-Bendib,"

Phrase: "M. et al."
Processing 00000000.tx.239: (1996) Screening for proteins with polyglutamine expansions in autosomal dominant cerebellar ataxias. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Screening for proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0220908:Screening [Health Care Activity]
   790   C0220909:screening [Functional Concept]
   790   C1698960:screening [Intellectual Product]
   790   C1710031:Screening [Diagnostic Procedure]
   790   C1710477:SCREENING [Research Activity]

Phrase: "with polyglutamine expansions"

Phrase: "in autosomal dominant cerebellar ataxias."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0007758:Cerebellar Ataxias [Sign or Symptom]
   861   C0443147:Autosomal dominant [Intellectual Product]
   812   C0004134:Ataxias [Sign or Symptom]
   812   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   812   C0596142:autosomal [Cell Component]
   812   C1527180:Dominant [Functional Concept]
   812   C1707522:Cerebellar [Tissue]
   729 E C0234366:Ataxic [Sign or Symptom]
Processing 00000000.tx.240: Hum. 

Phrase: "Hum."
Processing 00000000.tx.241: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.242: Genet., 5, 18871892.[Abstract/Free FullText] 13 Rubinsztein, D.C., Leggo, J., Crow, T.J., DeLisi, L.E., Walsh, C., Jain, S. and Paykel, E.S. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "18871892."

Phrase: "[Abstract/Free FullText"

Phrase: "] 13 Rubinsztein,"

Phrase: "D.C.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012358:D & C [Therapeutic or Preventive Procedure]
  1000   C0012764:D.C. [Geographic Area]
  1000   C1444662:D/C [Finding]
  1000   C1512015:D.C. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Leggo,"

Phrase: "J.,"

Phrase: "Crow,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0326391:Crow [Bird]
  1000   C1551958:Crow [Language]
  1000   C1555179:Crow [Population Group]

Phrase: "T.J.,"

Phrase: "DeLisi,"

Phrase: "L.E.,"

Phrase: "Walsh,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Jain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337694:Jain [Idea or Concept]
  1000   C1998092:Jain [Population Group]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Paykel,"

Phrase: "E.S."
Processing 00000000.tx.243: (1996) Analysis of polyglutamine-coding repeats in the TATA-binding protein in different human populations and in patients with schizophrenia and bipolar affective disorder. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Analysis of polyglutamine-coding repeats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in the TATA-binding protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "in different human populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "and in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1515981:And [Idea or Concept]

Phrase: "with schizophrenia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036341:Schizophrenia [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "bipolar affective disorder."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0005586:Bipolar affective disorder [Mental or Behavioral Dysfunction]
           Bipolar Disorder
   901   C0525045:Affective disorder [Mental or Behavioral Dysfunction]
   827   C0012634:Disorder [Disease or Syndrome]
   827   C0443156:Bipolar [Spatial Concept]
Processing 00000000.tx.244: Am. 

Phrase: "Am."
Processing 00000000.tx.245: J. 

Phrase: "J."
Processing 00000000.tx.246: Med. 

Phrase: "Med."
Processing 00000000.tx.247: Genet., 67, 495498.[ISI][Medline] 14 Koide, R., Kobayashi, S., Shimohata, T., Ikeuchi, T., Maruyama, M., Saito, M., Yamada, M., Takahashi, H. and Tsuji, S. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "67,"

Phrase: "495498."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 14 Koide,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kobayashi,"

Phrase: "S."

Phrase: ","

Phrase: "Shimohata,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ikeuchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Maruyama,"

Phrase: "M."

Phrase: ","

Phrase: "Saito,"

Phrase: "M."

Phrase: ","

Phrase: "Yamada,"

Phrase: "M."

Phrase: ","

Phrase: "Takahashi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Tsuji,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.248: (1999) A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? 

Phrase: "(1999"

Phrase: ")"

Phrase: "A neurological disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0027765:neurological disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "caused by an expanded CAG trinucleotide repeat"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0524894:Expanded Trinucleotide Repeat [Cell or Molecular Dysfunction]
   778   C0282537:Trinucleotide Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205229:expanded [Spatial Concept]
   748   C0205341:Repeat [Functional Concept]
   748   C1547730:Repeat [Temporal Concept]
   748   C1705914:Repeat [Conceptual Entity]
   714   C0015127:cause [Functional Concept]
   714   C1524003:Cause [Conceptual Entity]

Phrase: "in the TATA-binding protein gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "a new polyglutamine disease?"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.249: Hum. 

Phrase: "Hum."
Processing 00000000.tx.250: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.251: Genet., 8, 20472053.[Abstract/Free FullText] 15 Gostout, B., Liu, Q. and Sommer, S.S. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "20472053."

Phrase: "[Abstract/Free FullText"

Phrase: "] 15 Gostout,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Liu,"

Phrase: "Q."

Phrase: "and"

Phrase: "Sommer,"

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.252: (1993) Cryptic repeating triplets of purines and pyrimidines (cRRY(i)) are frequent and polymorphic: analysis of coding cRRY(i) in the proopiomelanocortin (POMC) and TATA-binding protein (TBP) genes. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Cryptic repeating triplets of purines"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   764   C0282537:Triplet Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0041095:Triplets [Family Group]
   726 E C0205174:Triplet [Quantitative Concept]

Phrase: "and"

Phrase: "pyrimidines"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0034289:Pyrimidines [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   966 E C0034284:Pyrimidine [Organic Chemical]

Phrase: "(cRRY"

Phrase: "(i))"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "are"

Phrase: "frequent"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0332183:Frequent [Temporal Concept]
   928 E C0376249:frequency [Quantitative Concept]
   928 E C0439603:Frequencies [Temporal Concept]
   928 E C0871396:Frequency [Quantitative Concept]
   928 E C1561548:Frequency [Qualitative Concept]
   928 E C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "polymorphic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1882417:Polymorphic [Qualitative Concept]
   928 E C0027950:Polymorph [Cell]

Phrase: ":"

Phrase: "analysis of coding cRRY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "(i) in the proopiomelanocortin (POMC)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021966:I- [Inorganic Chemical]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "TATA-binding protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "(TBP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: "genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.253: Am. 

Phrase: "Am."
Processing 00000000.tx.254: J. 

Phrase: "J."
Processing 00000000.tx.255: Hum. 

Phrase: "Hum."
Processing 00000000.tx.256: Genet., 52, 11821190.[ISI][Medline] 16 Koyano, S., Uchihara, T., Fujigasaki, H., Nakamura, A., Yagishita, S. and Iwabuchi, K. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "52,"

Phrase: "11821190."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 16 Koyano,"

Phrase: "S."

Phrase: ","

Phrase: "Uchihara,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Fujigasaki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nakamura,"

Phrase: "A.,"

Phrase: "Yagishita,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Iwabuchi,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.257: (1999) Neuronal intranuclear inclusions in spinocerebellar ataxia type 2: triple-labeling immunofluorescent study. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Neuronal intranuclear inclusions in spinocerebellar ataxia type 2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1366904:Intranuclear Inclusions [Cell Component]
   744   C0521390:Neuronal [Immunologic Factor]
   731   C0682689:neuron type [Cell]
   711   C1512693:Inclusion [Qualitative Concept]

Phrase: ":"

Phrase: "triple-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triple [Quantitative Concept]

Phrase: "labeling"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1167624:Labeling [Mental Process]
  1000   C1947902:Labeling [Manufactured Object]
  1000   C2827499:Labeling [Governmental or Regulatory Activity]
   966 E C0181496:Label [Manufactured Object]

Phrase: "immunofluorescent study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.258: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.259: Lett., 273, 117120.[ISI][Medline] 17 Huynh, D.P., Figueroa, K., Hoang, N. and Pulst, S.M. 

Phrase: "Lett.,"

Phrase: "273,"

Phrase: "117120."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 17 Huynh,"

Phrase: "D.P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512024:D.P. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Figueroa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hoang,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Pulst,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.260: (2000) Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nuclear localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "or"

Phrase: "inclusion body formation of ataxin-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "are"

Phrase: "not necessary for SCA2 pathogenesis"

Phrase: "in mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "or"

Phrase: "human."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]
Processing 00000000.tx.261: Nat. 

Phrase: "Nat."
Processing 00000000.tx.262: Genet., 26, 4450.[ISI][Medline] 18 Ishikawa, K., Fujigasaki, H., Saegusa, H., Ohwada, K., Fujita, T., Iwamoto, H., Komatsuzaki, Y., Toru, S., Toriyama, H., Watanabe, M. etal. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "26,"

Phrase: "4450."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 18 Ishikawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fujigasaki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saegusa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ohwada,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fujita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Iwamoto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Komatsuzaki,"

Phrase: "Y.,"

Phrase: "Toru,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332567:toru [Pathologic Function]

Phrase: "S."

Phrase: ","

Phrase: "Toriyama,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Watanabe,"

Phrase: "M. etal."
Processing 00000000.tx.263: (1999) Abundant expression and cytoplasmic aggregations of [alpha]1A voltage- dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Abundant expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "cytoplasmic aggregations of [alpha"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0439095:Alpha [Intellectual Product]
   812   C2003941:Alpha [Intellectual Product]
   812   C2350010:Alpha [Qualitative Concept]

Phrase: "]1A voltage- dependent calcium channel protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   839   C0805431:Calcium/Protein [Quantitative Concept]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "associated with neurodegeneration"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in spinocerebellar ataxia type 6."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752124:Spinocerebellar Ataxia Type 6 [Disease or Syndrome]
           Spinocerebellar Ataxia-6
   923   C2700586:SPINOCEREBELLAR ATAXIA 6 [Gene or Genome]
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   861   C1960442:Type 6 [Intellectual Product]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]
Processing 00000000.tx.264: Hum. 

Phrase: "Hum."
Processing 00000000.tx.265: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.266: Genet., 8, 11851193.[Abstract/Free FullText] 19 Davies, S.W., Beardsall, K., Turmaine, M., DiFiglia, M., Aronin, N. and Bates, G.P. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "11851193."

Phrase: "[Abstract/Free FullText"

Phrase: "] 19 Davies,"

Phrase: "S.W.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Beardsall,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Turmaine,"

Phrase: "M."

Phrase: ","

Phrase: "DiFiglia,"

Phrase: "M."

Phrase: ","

Phrase: "Aronin,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Bates"

Phrase: ","

Phrase: "G.P."
Processing 00000000.tx.267: (1998) Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions? 

Phrase: "(1998"

Phrase: ")"

Phrase: "Are"

Phrase: "neuronal intranuclear inclusions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C1366904:Intranuclear Inclusions [Cell Component]
   827   C0521390:Neuronal [Immunologic Factor]
   793   C1512693:Inclusion [Qualitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "the common neuropathology of triplet-repeat disorders"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   748   C1540677:neuropathology [Pathologic Function]
   748   C1555824:Neuropathology [Intellectual Product]

Phrase: "with polyglutamine-repeat expansions?"
Processing 00000000.tx.268: Lancet, 351, 131133.[ISI][Medline] 20 Ross, C.A. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "351,"

Phrase: "131133."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 20 Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0331968:Ross [Health Care Related Organization]
   861   C2699100:Ross [Bird]

Phrase: "C."

Phrase: "A."
Processing 00000000.tx.269: (1997) Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? 

Phrase: "(1997"

Phrase: ")"

Phrase: "Intranuclear neuronal inclusions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1366904:Intranuclear Inclusions [Cell Component]
   793   C1512693:Inclusion [Qualitative Concept]

Phrase: ":"

Phrase: "a common pathogenic mechanism for glutamine-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "repeat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205341:Repeat [Functional Concept]
  1000   C1547730:Repeat [Temporal Concept]
  1000   C1705914:Repeat [Conceptual Entity]

Phrase: "neurodegenerative diseases?"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.270: Neuron, 19, 11471150.[ISI][Medline] 21 Kao, C.C., Lieberman, P.M., Schmidt, M.C., Zhou, Q., Pei, R. and Berk,A.J. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "19,"

Phrase: "11471150."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 21 Kao,"

Phrase: "C.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Lieberman,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Schmidt,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Zhou,"

Phrase: "Q.,"

Phrase: "Pei,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0814202:PEI [Intellectual Product]
  1000   C1880568:PEI [Therapeutic or Preventive Procedure]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Berk,"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]
Processing 00000000.tx.271: (1990) Cloning of a transcriptionally active human TATA binding factor. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Cloning of a transcriptionally active human TATA binding factor."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0525049:Human Cloning [Research Activity]
   742   C0009015:Cloning [Research Activity]
Processing 00000000.tx.272: Science, 248, 16461650.[ISI][Medline] 22 Green, M.R. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "248,"

Phrase: "16461650."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 22 Green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332583:Green [Qualitative Concept]

Phrase: "M."

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.273: (2000) TBP-associated factors (TAFIIs): multiple, selective transcriptional mediators in common complexes. 

Phrase: "(2000"

Phrase: ")"

Phrase: "TBP-associated factors"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C1136066:TATA-Binding Protein Associated Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   900   C0144555:TATA-Binding Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           TATA-Binding Protein
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0243122:binding [Functional Concept]
   804   C0332281:Associated [Qualitative Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   771 E C0750490:Associate [Idea or Concept]
   771   C1521761:Factor [Functional Concept]
   771 E C1706221:Associate [Professional or Occupational Group]
   771   C2827422:Factor [Conceptual Entity]

Phrase: "(TAFIIs"

Phrase: ")"

Phrase: ":"

Phrase: "multiple, selective transcriptional mediators in common complexes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   714 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.274: Trends Biochem. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem."
Processing 00000000.tx.275: Sci., 25, 5963.[ISI][Medline] 23 Tan, S. and Richmond, T.J. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "25,"

Phrase: "5963."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 23 Tan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302595:tan [Individual Behavior]
   861   C1537110:Tan [Clinical Attribute]
   861   C3275241:Tan [Qualitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Richmond,"

Phrase: "T.J."
Processing 00000000.tx.276: (1998) Eukaryotic transcription factors. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Eukaryotic transcription factors."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040649:Transcription [Genetic Function]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.277: Curr. 

Phrase: "Curr."
Processing 00000000.tx.278: Opin. 

Phrase: "Opin."
Processing 00000000.tx.279: Struct. 

Phrase: "Struct."
Processing 00000000.tx.280: Biol., 8, 4148.[ISI][Medline] 24 Lescure, A., Lutz, Y., Eberhard, D., Jacq, X., Krol, A., Grummt, I., Davidson, I., Chambon, P. and Tora, L. 

Phrase: "Biol.,"

Phrase: "8,"

Phrase: "4148."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 24 Lescure,"

Phrase: "A.,"

Phrase: "Lutz,"

Phrase: "Y.,"

Phrase: "Eberhard,"

Phrase: "D."

Phrase: ","

Phrase: "Jacq,"

Phrase: "X.,"

Phrase: "Krol,"

Phrase: "A.,"

Phrase: "Grummt,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Davidson,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Chambon,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Tora,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.281: (1994) The N-terminal domain of the human TATA-binding protein plays a role in transcription from TATA-containing RNA polymerase II and III promoters. 

Phrase: "(1994"

Phrase: ")"

Phrase: "The N-terminal domain of the human TATA-binding protein"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   777   C1323338:N-terminal binding [Molecular Function]
   775   C1514535:Protein Binding Domain [Amino Acid Sequence]
   757   C0162808:Protein Domain [Spatial Concept]
   757   C1514562:Protein Domain [Amino Acid Sequence]
   739   C0205088:Terminal [Temporal Concept]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C3541951:Domain [Intellectual Product]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "from TATA-containing RNA polymerase II"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0035679:RNA Polymerase II [Amino Acid, Peptide, or Protein,Enzyme]
   853   C0140652:RNA II [Nucleic Acid, Nucleoside, or Nucleotide]
   840   C0035681:RNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C2984241:RNA polymerase [Functional Concept]
   804   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "III promoters."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.282: EMBO J., 13, 11661175.[Abstract] 25 Kuddus, R. and Schmidt, M.C. 

Phrase: "EMBO J.,"

Phrase: "13,"

Phrase: "11661175."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 25 Kuddus,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Schmidt,"

Phrase: "M.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.283: (1993) Effect of the non-conserved N-terminus on the DNA binding activity of the yeast TATA binding protein [published erratum appears in Nucleic Acids Res. (1993) 21, 2962]. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Effect of the non-conserved N-terminus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on the DNA binding activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C2266866:Binding Activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C1148673:DNA Binding [Genetic Function]

Phrase: "of the yeast TATA binding protein"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C0872306:Yeast Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "[published erratum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282417:Published Erratum [Intellectual Product]

Phrase: "appears in Nucleic Acids Res."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0001128:Acids [Chemical]
   760   C0007610:Nucleic [Cell Component]
   760   C0700364:APPEAR [Qualitative Concept]
   760   C2347379:RES [Finding]
   726 E C0202406:Acid [Laboratory Procedure]

Phrase: "(1993"

Phrase: ")"

Phrase: "21,"

Phrase: "2962"

Phrase: "]."
Processing 00000000.tx.284: Nucleic Acids Res., 21, 17891796.[Abstract] 26 Imbert, G., Trottier, Y., Beckmann, J. and Mandel, J.L. 

Phrase: "Nucleic Acids Res.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "21,"

Phrase: "17891796."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 26 Imbert,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Trottier,"

Phrase: "Y.,"

Phrase: "Beckmann,"

Phrase: "J."

Phrase: "and"

Phrase: "Mandel,"

Phrase: "J.L."
Processing 00000000.tx.285: (1994) The gene for the TATA binding protein (TBP) that contains a highly polymorphic protein coding CAG repeat maps to 6q27. 

Phrase: "(1994"

Phrase: ")"

Phrase: "The gene for the TATA binding protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0751455:gene protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0017337:Gene [Gene or Genome]

Phrase: "(TBP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0144555:TATA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: "that"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a highly polymorphic protein coding CAG repeat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0205341:Repeat [Functional Concept]
   799   C1547730:Repeat [Temporal Concept]
   799   C1705914:Repeat [Conceptual Entity]

Phrase: "maps to 6q27."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0024779:Map [Manufactured Object]
   790   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1521580:6q27 [Cell Component]
   790   C1706473:Map [Conceptual Entity]
Processing 00000000.tx.286: Genomics, 21, 667668.[ISI][Medline] 27 Jones, A.L., Middle, F., Guy, C., Spurlock, G., Cairns, N.J., McGuffin, P., Craddock, N., Owen, M. and ODonovan, M.C. 

Phrase: "Genomics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: "21,"

Phrase: "667668."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 27 Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443013:Jones [Intellectual Product]

Phrase: "A.L., Middle,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0444598:Middle [Spatial Concept]
   827   C0549183:middle [Spatial Concept]
   827   C1552826:middle [Idea or Concept]
   771 E C0205098:Medial [Spatial Concept]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Guy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018408:GUY [Geographic Area]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Spurlock,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Cairns,"

Phrase: "N.J.,"

Phrase: "McGuffin,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Craddock,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Owen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "ODonovan,"

Phrase: "M.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.287: (1997) No evidence for expanded polyglutamine sequences in bipolar disorder and schizophrenia. 

Phrase: "(1997"

Phrase: ")"

Phrase: "No evidence for expanded polyglutamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "sequences in bipolar disorder"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0005586:Bipolar Disorder [Mental or Behavioral Dysfunction]
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0012634:Disorder [Disease or Syndrome]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C0443156:Bipolar [Spatial Concept]
   770   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "schizophrenia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036341:Schizophrenia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.288: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.289: Psychiatry, 2, 478482.[ISI][Medline] 28 Saudou, F., Finkbeiner, S., Devys, D. and Greenberg, M.E. 

Phrase: "Psychiatry,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033872:Psychiatry [Professional or Occupational Group]
  1000   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   928 E C0205487:Psychiatric [Functional Concept]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "478482."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 28 Saudou,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Finkbeiner,"

Phrase: "S."

Phrase: ","

Phrase: "Devys,"

Phrase: "D."

Phrase: "and"

Phrase: "Greenberg,"

Phrase: "M."

Phrase: "E."
Processing 00000000.tx.290: (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Huntingtin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0252274:Huntingtin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415504:HUNTINGTIN [Gene or Genome]

Phrase: "acts in the nucleus to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0007610:Nucleus [Cell Component]
   760   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "but"

Phrase: "death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "correlate with the formation of intranuclear inclusions."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1366904:Intranuclear Inclusions [Cell Component]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]
   714   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.291: Cell, 95, 5566.[ISI][Medline] 29 Klement, I.A., Skinner, P.J., Kaytor, M.D., Yi, H., Hersch, S.M., Clark, H.B., Zoghbi, H.Y. and Orr, H.T. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "95,"

Phrase: "5566."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 29 Klement,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "A.,"

Phrase: "Skinner,"

Phrase: "P.J.,"

Phrase: "Kaytor,"

Phrase: "M.D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Yi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hersch,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Clark,"

Phrase: "H.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0919534:H-B [Gene or Genome]

Phrase: "Zoghbi,"

Phrase: "H.Y."

Phrase: "and"

Phrase: "Orr,"

Phrase: "H.T."
Processing 00000000.tx.292: (1998) Ataxin-1 nuclear localization and aggregation: role in polyglutamine- induced disease in SCA1 transgenic mice. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Ataxin-1 nuclear localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0475264:Localisation [Functional Concept]
   812   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: ":"

Phrase: "role in polyglutamine- induced disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in SCA1 transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.293: Cell, 95, 4153[ISI][Medline] 30 Cummings, C.J. and Zoghbi, H.Y. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "95,"

Phrase: "4153"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 30 Cummings,"

Phrase: "C.J."

Phrase: "and"

Phrase: "Zoghbi,"

Phrase: "H.Y."
Processing 00000000.tx.294: (2000) Fourteen and counting: unraveling trinucleotide repeat diseases. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Fourteen"

Phrase: "and"

Phrase: "counting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: ":"

Phrase: "unraveling trinucleotide repeat diseases."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0012634:Diseases [Disease or Syndrome]
   741 E C1836721:MALS [Finding]
   741 E C3538764:MALS [Gene or Genome]
   741 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.295: Hum. 

Phrase: "Hum."
Processing 00000000.tx.296: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.297: Genet., 9, 909916.[Abstract/Free FullText] 31 Boutell, J.M., Thomas, P., Neal, J.W., Weston, V.J., Duce, J., Harper, P.S. and Jones, A.L. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "9,"

Phrase: "909916."

Phrase: "[Abstract/Free FullText"

Phrase: "] 31 Boutell,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Thomas,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Neal,"

Phrase: "J.W., Weston,"

Phrase: "V.J.,"

Phrase: "Duce,"

Phrase: "J.,"

Phrase: "Harper,"

Phrase: "P.S."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0234833:P s [Organ or Tissue Function]
  1000   C0722388:P & S [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "A.L."
Processing 00000000.tx.298: (1999) Aberrant interactions of transcriptional repressor proteins with the Huntingtons disease gene product, huntingtin. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Aberrant interactions of transcriptional repressor proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0872079:interactions protein [Molecular Function]
   719   C1704675:Interaction [Functional Concept]

Phrase: "with the Huntingtons disease gene product,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   858   C0872189:Huntington gene [Gene or Genome]
   833   C1416989:MAL gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C1514468:product [Entity]
   812   C1704444:Product [Quantitative Concept]

Phrase: "huntingtin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0252274:Huntingtin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415504:HUNTINGTIN [Gene or Genome]
Processing 00000000.tx.299: Hum. 

Phrase: "Hum."
Processing 00000000.tx.300: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.301: Genet., 8, 16471655.[Abstract/Free FullText] 32 Kazantsev, A., Preisinger, E., Dranovsky, A., Goldgaber, D. and Housman, D. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "16471655."

Phrase: "[Abstract/Free FullText"

Phrase: "] 32 Kazantsev,"

Phrase: "A.,"

Phrase: "Preisinger,"

Phrase: "E.,"

Phrase: "Dranovsky,"

Phrase: "A.,"

Phrase: "Goldgaber,"

Phrase: "D."

Phrase: "and"

Phrase: "Housman,"

Phrase: "D."
Processing 00000000.tx.302: (1999) Insoluble detergent-resistant aggregates form between pathological and non-pathological lengths of polyglutamine in mammalian cells. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Insoluble detergent-resistant aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205418:aggregates [Qualitative Concept]

Phrase: "form between pathological"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0030664:Pathological [Biomedical Occupation or Discipline]
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C1521733:Pathological [Functional Concept]
   790   C1522492:Form [Functional Concept]
   718 E C0205469:pathology [Functional Concept]
   718 E C0677042:pathology [Pathologic Function]

Phrase: "and"

Phrase: "non-pathological lengths of polyglutamine"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1444754:Lengths [Quantitative Concept]
   726 E C1706316:LENGTH [Research Activity]

Phrase: "in mammalian cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.303: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.304: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.305: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.306: USA, 96, 1140411409.[Abstract/Free FullText] 33 Huang, C.C., Faber, P.W., Persichetti, F., Mittal, V., Vonsattel, J.P., MacDonald, M.E. and Gusella, J.F. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "96,"

Phrase: "1140411409."

Phrase: "[Abstract/Free FullText"

Phrase: "] 33 Huang,"

Phrase: "C.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Faber,"

Phrase: "P.W., Persichetti,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Mittal,"

Phrase: "V.,"

Phrase: "Vonsattel,"

Phrase: "J.P.,"

Phrase: "MacDonald,"

Phrase: "M."

Phrase: "E."

Phrase: "and"

Phrase: "Gusella,"

Phrase: "J.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.307: (1998) Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Amyloid formation by mutant huntingtin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: ":"

Phrase: "threshold,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449864:Threshold [Qualitative Concept]

Phrase: "progressivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0205329:Progressive [Functional Concept]

Phrase: "and"

Phrase: "recruitment of normal polyglutamine proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1158950:protein recruitment [Cell Function]
   760   C2949735:Recruitment [Activity]
Processing 00000000.tx.308: Somat. 

Phrase: "Somat."
Processing 00000000.tx.309: Cell Mol. 

Phrase: "Cell Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0027960:Mole [Neoplastic Process]
   861   C0324740:Mole [Mammal]
   861   C0439189:Mole [Quantitative Concept]
   861   C1456781:mole [Neoplastic Process]
   861   C1824986:mol [Gene or Genome]
   777 E C0026367:Molar [Body Part, Organ, or Organ Component]
   761 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.310: Genet., 24, 217233.[ISI][Medline] 34 Perez, M.K., Paulson, H.L., Pendse, S.J., Saionz, S.J., Bonini, N.M. and Pittman, R.N. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "24,"

Phrase: "217233."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 34 Perez,"

Phrase: "M."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Paulson,"

Phrase: "H.L., Pendse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2346686:h l [Quantitative Concept]

Phrase: "S."

Phrase: "J.,"

Phrase: "Saionz,"

Phrase: "S."

Phrase: "J.,"

Phrase: "Bonini,"

Phrase: "N.M."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2347350:N/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0441923:M+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Pittman,"

Phrase: "R.N."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0687673:R.N. [Professional or Occupational Group]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.311: (1998) Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Recruitment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2949735:Recruitment [Activity]

Phrase: "and"

Phrase: "the role of nuclear localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in polyglutamine-mediated aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332621:Aggregation [Functional Concept]
   827   C0439168:% aggregation [Quantitative Concept]
   755 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.312: J. 

Phrase: "J."
Processing 00000000.tx.313: Cell Biol., 143, 14571470.[Abstract/Free FullText] 35 Wang, G., Ide, K., Nukina, N., Goto, J., Ichikawa, Y., Uchida, K., Sakamoto, T. and Kanazawa, I. 

Phrase: "Cell Biol.,"

Phrase: "143,"

Phrase: "14571470."

Phrase: "[Abstract/Free FullText"

Phrase: "] 35 Wang,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nukina,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Goto,"

Phrase: "J.,"

Phrase: "Ichikawa,"

Phrase: "Y.,"

Phrase: "Uchida,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sakamoto,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Kanazawa,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.314: (1997) Machado-Joseph disease gene product identified in lymphocytes and brain. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Machado-Joseph disease gene product"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1416989:MAL gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]
   717   C0024408:Machado-Joseph Disease [Disease or Syndrome]

Phrase: "identified in lymphocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0024264:Lymphocytes [Cell]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.315: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.316: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.317: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.318: Commun., 233, 476479.[ISI][Medline]

Phrase: "Commun.,"

Phrase: "233,"

Phrase: "476479."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

